Datenquellen im TIB-Portal   Hilfe zur Suche

Unser Tipp: Melden Sie sich an, um alle Funktionen im TIB-Portal optimal nutzen zu können!

PSS10 A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICO (Englisch)

In: VALUE IN HEALTH   ;  14 ,  3  ;  A55  ;  2011
  • ISSN:
    1098-3015
  • Aufsatz (Zeitschrift)  /  Print

Wie erhalte ich diesen Titel?

© Metadata Copyright the British Library Board and other contributors. All rights reserved.

Inhaltsverzeichnis – Band 14, Ausgabe 3

Zeige alle Jahrgänge und Ausgaben

Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.

A1
CO1 COMPARATIVE EFFECTIVENESS ANALYSIS OF TNF BLOCKERS IN RHEUMATOID ARTHRITIS (RA) PATIENTS IN A REAL-WORLD SETTING
Bonafede, R. P. / Pearson, D. / Babich, J. / Chastek, B. / Becker, L. / Watson, C. / Chaudhari, S. / Harrison, D. J. / Gandra, S. R. | 2011
A4
SB3 INNOVATIVE DESIGN FOR A COMPARATIVE EFFECTIVENESS STUDY OF SCHIZOPHRENIA TREATMENTS: ANALYSIS OF RECORD REVIEW DATA INCORPORATING RANDOMIZATION AND PROPENSITY SCORE MATCHING
McCarrier, K. P. / Durkin, M. B. / Dirani, R. / Markowitz, M. / Slabaugh, S. L. / Martin, M. L. | 2011
A5
CE4 USING DYNAMIC TRANSMISSION MODELS TO ESTIMATE THE COST EFFECTIVENESS OF VACCINES: FOUR DIFFERENT METHODS AND THEIR RELEVANCE FOR DECISION MAKERS
Mauskopf, J. / Talbird, S. E. / Standaert, B. | 2011
A8
MC3 IMPACT OF MULTIPLE MEDICATION COMPLIANCE ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH TYPE II DIABETES AND COMORBID HYPERTENSION CONTROLLING FOR ENDOGENEITY BIAS
An, J. J. / Nichol, M. B. | 2011
A9
EE4 BOOTSTRAPPING USED TO PROVIDE ROBUST MEAN AND VARIANCE ESTIMATES FOR COMPARING PATIENTS TREATED WITH LIRAGLUTIDE TO A LARGE COMPARISON COHORT
McAdam Marx, C. / Ye, X. / Bouchard, J. / Aagren, M. / Conner, C. / Brixner, D. | 2011
A10
MD1 USING COST-EFFECTIVENESS INFORMATION TO ALLOCATE MEDICARE RESOURCES – HOW MUCH MORE HEALTH FOR THE MONEY?
Chambers, J. D. / Cohen, J. T. / Neumann, P. J. / Lord, J. / Buxton, M. | 2011
A12
PHP4 WHEN STAKEHOLDERS DON'T AGREE: DISCREPANCIES IN MAB “APPROVALS” OVER THE PAST TEN YEARS
Miller, K. L. / Stevens, C. A. | 2011
A13
PHP10 THE TEMPORAL ASSOCIATION BETWEEN PRESCRIBED OPIOIDS AND THE NATIONAL DEATH RATE DUE TO OPIOID POISONING
Gokhale, M. N. / Martin, B. | 2011
A14
PHP16 ANALYZING THE EUROPEAN EXTERNAL REFERENCE PRICING SYSTEM USING SPECTRAL GRAPH THEORY
Lindgren, P. / kerborg, x. | 2011
A15
PHP23 THE IMPACT OF MEDICARE PART D ON PRESCRIPTION VOLUME AND OUT-OF-POCKET COSTS OF MEDICALLY NECESSARY DRUGS
Sepulveda, B. / Doyle, J. / White, C. | 2011
A16
PHP28 COMPLIANCE WITH TREATMENT GUIDELINE RECOMMENDATIONS: USE OF OVER-THE-COUNTER MEDICATIONS IN PATIENTS RECEIVING BISPHOSPHONATES, ANTIEPILEPTICS, OR CHRONIC OPIOIDS
Barnes, K. D. / Heaton, P. C. | 2011
A17
PHP35 DECISION MAKING IN BRAZIL BASED ON HEALTH TECHNOLOGY ASSESSMENT: THE GOOD, THE BAD, AND THE FUTURE
Machado, M. / Fonseca, E. / Fonseca, M. | 2011
A18
PHP41 THE CHANGING LANDSCAPE OF ORPHAN DRUG PROVISION IN THE EU5 AND THE UNITED STATES
McConkey, D. | 2011
A20
PHP52 INCREASE IN UNINTENTIONAL FATAL POISONINGS BY NOXIOUS SUBSTANCES IN KANSAS CITY, MISSOURI, FROM 1999 TO 2008
Liu, Y. / Cai, J. / Hong, L. / Hoff, G. L. / Okah, F. A. | 2011
A21
PHP59 THE AVAILABILITY AND SIGNIFICANCE OF COST-EFFECTIVENESS DATA FOR INFORMING DECISIONS TO ADD NEW DRUGS TO THE NATIONAL LIST OF HEALTH SERVICES IN ISRAEL
Greenberg, D. / Wacht, O. / Siebzehner, M. I. | 2011
A22
PHP64 THE RELATIONSHIP BETWEEN FINANCIAL IMPACT AND THE LIKELIHOOD OF DRUG REIMBURSEMENT IN THE AUSTRALIAN HEALTH CARE SYSTEM
Mauskopf, J. / Chirila, C. / Masaquel, C. / Boye, K. S. / Bowman, L. / Birt, J. / Grainger, D. | 2011
A23
PHP69 HOW MUCH FOR A QALY IN KOREA
Kim, Y. / Shin, S. / Park, S. / Song, H. / Park, J. / Bae, E. / Ahn, J. | 2011
A24
PHP74 CLINICAL TRIAL LEARNING CURVES AFFECT OUTCOMES MEASUREMENT, PATIENT SAFETY AND TRIAL SUCCESS: CONTRIBUTING FACTORS AND A POTENTIAL SOLUTION IN CLINICAL TRIAL SIMULATION
Spinner, D. S. / Walter, J. W. / Vazquez-Gragg, M. / Bloise, T. / Stafford-Smith, M. / Faulkner, E. C. / Taekman, J. M. | 2011
A25
PHP80 RELATIONSHIP OF HERBAL KNOWLEDGE TOWARDS ATTITUDE FORMATION AMONG FUTURE PHARMACISTS
Sura, S. D. / Chabria, A. / Sansgiry, S. | 2011
A26
PHP85 APPLYING FUZZY MULTIPLE CRITERIA DECISION MAKING TO ESTABLISH A NEW HEALTH TECHNOLOGY ASSESSMENT SYSTEM WITH COVERAGE IMPLICATIONS IN TAIWAN NATIONAL HEALTH INSURANCE
Lin, C. W. | 2011
A27
PHP90 TRENDS IN UTILIZATION OF PREGNANCY RISK CATEGORY D AND X DRUGS AMONG PREGNANT WOMEN IN THE UNITED STATES
Shah, A. J. / Patil, D. S. / Kadakia, A. / Aparasu, R. R. | 2011
A28
PHP95 EXPECTED CHANGES IN HEALTH CARE UTILIZATION DUE TO PATIENT PROTECTION AND AFFORDABLE CARE ACT
Ghushchyan, V. H. / Sullivan, P. W. / Naim, A. / Nair, K. V. | 2011
A30
PHP106 DISPARITY IN ACCESS TO NOVEL DIABETIC AGENTS FOR MEDICARE PART D ELDERLY COMPARED TO COMMERCIAL INSURED PATIENTS: INSIGHT INTO DOWNSTREAM EFFECTS OF CMS FORMULARY COVERAGE GUIDELINES FOR PDP'S
Schwartz, E. L. / Davis, E. A. / Belazi, D. / Hasan, S. | 2011
A31
PHP112 DEFINITIONAL CRITERIA FOR CHRONIC FATIGUE SYNDROME: A CRITICAL REVIEW
Christley, Y. / Duffy, T. / Martin, C. R. | 2011
A32
PCV3 RISK OF HOSPITALIZATIONS FOR VENOUS THROMBOEMBOLISM IN ATYPICAL VERSUS TYPICAL ANTIPSYCHOTIC USERS IN A NATIONAL SAMPLE OF MEDICARE BENEFICIARIES: A CLAIMS DATA ANALYSIS
Dharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. | 2011
A34
PCV15 PREDICTORS OF THE COMBINED DIAGNOSIS HYPERLIPIDEMIA AND HYPERTENSION - A NHANES 2007-2008 STUDY
Bhounsule, P. / Abughosh, S. | 2011
A35
PCV20 PERSISTENCE WITH STATINS AND PRIMARY PREVENTION OF CARDIOVASCULAR EVENTS: A POPULATION-BASED COHORT STUDY
Chodick, G. / Shalev, V. / Goldstein, I. / Porath, A. / Simah, V. | 2011
A37
PCV31 ASSOCIATION BETWEEN HEART FAILURE AND IN-HOSPITAL MORTALITY IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
Phatak, H. / Pan, X. / Kawabata, H. | 2011
A38
PCV36 EVALUATION OF THE HOSPITAL RESOURCE UTILIZATION ASSOCIATED WITH TOLVAPTAN USAGE AMONG HEART FAILURE PATIENTS WITH HYPONATREMIA FROM THE EVEREST TRIAL
Dasta, J. F. / Chiong, J. R. / Kim, S. / Lin, J. | 2011
A39
PCV42 A DECISION MODELING APPROACH TO EVALUATE THE COST-EFFECTIVENESS OF PRASUGREL VERSUS CLOPIDOGREL IN PATIENTS WITH PLANNED PERCUTANEOUS CORONARY INTERVENTION
Rao, S. / Lin, F. J. / Ojo, O. / Patel, V. / Yu, S. / Zhan, L. / Touchette, D. R. | 2011
A40
PCV47 COST-EFFECTIVENESS OF FONDAPARINUX AND ENOXAPARIN IN PATIENTS WITH NON ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME IN BRAZIL
Pepe, C. / Machado, M. / Olimpio, A. / Canella, M. / Ramos, R. | 2011
A42
PCV58 ASSOCIATION BETWEEN HEART FAILURE AND RESOURCE UTILIZATION IN ST-ELEVATION MYOCARDIAL INFARCTION PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION
Pan, X. / Kawabata, H. / Phatak, H. | 2011
A43
PCV63 THE IMPACT OF CARDIOVASCULAR DISEASE HOSPITALIZATIONS ON CHANGES IN PATIENT ADHERENCE TO ANTIHYPERTENISVE DRUGS IN A MEDICAID POPULATION
Yan, X. / Shaya, F. T. | 2011
A44
PCV68 FACTORS ASSOCIATED WITH NON-ADMINISTRATION OF ORDERED PHARMACOLOGIC VENOUS THROMBOEMBOLISM PROPHYLAXIS DOSES
Shermock, K. M. / Shafir, V. / Streiff, M. B. / Lavallee, D. M. / Pinto, B. L. / Haut, E. / Kraus, P. / Efird, L. / Elder, S. / Rand, C. | 2011
A45
PCV74 ASSESSMENT OF KNOWLEDGE ABOUT HYPERTENSION (HTN) AMONG HYPERTENSIVE PATIENTS IN SOUTHERN PUNJAB, PAKISTAN
Atif, M. / Asif, M. / Saleem, F. / Ahmad, N. / Saqib, N. | 2011
A46
PCV79 IMPACT OF DISEASE MANAGEMENT PROGRAM “DE TODO CORAZON” OF MUTUAL SER HMO TO CONTROL CARDIOVASCULAR RISK, COHORT 2004-2009, COLOMBIA
Paz, J. J. / Granados, C. E. / Morales, C. / Rodriguez, N. / Buitrago, L. A. / Guete, A. / Caceres, H. A. / Ramirez, P. / Pardo, R. | 2011
A47
PCV84 EFFECTIVENESS OF A MEDICAL EDUCATION INTERVENTION TO TREAT HYPERTENSION IN PRIMARY CARE
Martinez Valverde, S. / Reyes Morales, H. / Castro Rios, A. / Perez Cuevas, R. / Klunder Klunder, M. / Salinas Escudero, G. | 2011
A48
PCV90 FACTORS ASSOCIATED WITH SELECTIONS OF STATINS AMONG PATIENTS IN A LARGE EMPLOYER-BASED CLAIMS DATABASE
Zhao, Z. / Peng, X. / Bae, J. P. / Sponseller, C. A. / LeNarz, L. A. | 2011
A49
PCV95 USING COMPUTERIZED PHYSICIAN ORDER ENTRY OF ANTI-HYPERTENSIVE MEDICATIONS TO CONNECT INDICATIONS WITH PRESCRIBING AND IMPROVE PROBLEM LIST DOCUMENTATION
Galanter, W. / Walton, S. / Falck, S. / Rosencranz, H. / Adimadhyam, S. | 2011
A50
PCV100 HEALTH CARE UTILIZATION AND COSTS FOR A MEDICATION THERAPY MANAGEMENT (MTM) PROGRAM
Pinto, S. L. / Partha, G. | 2011
A52
PCV111 IDENTIFICATION OF RESPONSE SHIFT AMONG HYPERTENSIVE PATIENTS WITH CORONARY ARTERY DISEASE USING TWO STRUCTURAL EQUATION MODELING TECHNIQUES
Gandhi, P. K. / Ried, L. D. / Huang, I. C. / Kimberlin, C. / Kauf, T. / Suh, D. C. | 2011
A53
PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN
Berbari, J. / Reynolds, S. / Heil-Ruess, M. / Iskedjian, M. | 2011
A56
PSS20 MEDIATION MODELING AND MEASUREMENT CHARACTERISTICS OF THE ITCH SEVERITY SCORE FROM A PHASE 2B TRIAL OF ORAL CP-690-550 IN PATIENTS WITH MODERATE TO-SEVERE PLAQUE PSORIASIS
Mamolo, C. / Bushmakin, A. G. / Cappelleri, J. C. / Stewart, M. | 2011
A57
PSS25 MEDICATION ADHERENCE TO TOPICAL MEDICATIONS AND HEALTHCARE EXPENDITURES IN MEDICAID-ENROLLED CHILD WITH ATOPIC DERMATITIS
Ou, H. T. / Feldman, S. R. / Balkrishnan, R. | 2011
A58
PSS30 BURDEN OF INFANTILE HEMANGIOMA: DEVELOPMENT OF A QUESTIONNAIRE
Taieb, C. / Voisard, J. J. / Ruiz, F. | 2011
A59
PSY6 TRANSFUSIONAL IRON OVERLOAD (TIO) MONITORING AND TREATMENT: FINDINGS FROM AN ELECTRONIC MEDICAL RECORDS REVIEW STUDY AT THE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE
Duh, M. S. / Wetzstein, G. / Guo, A. / Sasane, M. / Sarda, S. P. / Korves, C. / Wang, S. T. / Wei, R. / Clinton, B. / Ray, L. | 2011
A60
PSY11 BURDEN OF ILLNESS IN FIBROMYALGIA SYNDROME: THE PATIENTS' PERSPECTIVES
Lee, S. S. / Kim, S. H. / Kim, S. K. / Lee, C. K. / Lee, H. S. / Lee, S. H. / Park, Y. B. / Ko, S. K. / Park, H. J. | 2011
A61
PSY16 PROJECTING THE LIFETIME ECONOMIC COSTS OF OBESITY: A BMI TRAJECTORY-BASED MODEL
Wang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Wong, E. / Flum, D. / Arterburn, D. / Sullivan, S. D. | 2011
A62
PSY21 COST-EFFECTIVENESS ANALISYS OF TREATMENT WITH AMFEPRAMONE (DIETHYLPROPION) IN OBESITY IN MEXICO
Ramirez Ramirez, M. / Soto-Molina, H. / Rizzoli-Cordoba, A. / Delgado-Ginebra, I. / Pizarro-Castellanos, M. | 2011
A63
PSY26 IMPACT OF HYPONATREMIA ON PATIENT OUTCOMES AND HEALTH CARE RESOURCE UTILIZATION IN HOSPITALIZED PATIENTS
Deitelzweig, S. / Amin, A. / Lin, J. / Belk, K. / Baumer, D. / Lowe, T. | 2011
A64
PSY31 HEMOPHILIA A: PATIENT IMPACT AND ECONOMIC BURDEN OF THE DISEASE
Strandberg-Larsen, M. / Gater, A. / Thomson, A. | 2011
A65
PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)
Jolly, M. / Kosinski, M. / Garris, C. P. / Jhingran, P. M. / Mikolaitis, R. A. / Dennis, G. / Wallace, D. J. / Clarke, A. / Parke, A. / Dooley, M. A. | 2011
A66
PSY42 EPIDEMIOLOGY AND QALITY OF LIFE OF ANEMIC PATIENTS ON DIALYSIS IN RUSSIA: PATIENT-REPORTED DATA
Vorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. / Eliseeva, E. / Baev, V. / Vezikova, N. | 2011
A67
PSY47 WILLINGNESS TO PAY (WTP) FOR WEIGHT LOSS COACHING: RESULTS FROM THE POWER TRIAL
Alavi, R. / Appel, L. / Brancati, F. / Clark, J. / Mohr, P. / Daumit, G. | 2011
A69
PSY59 IMPACT OF OBESITY ON AGE-SPECIFIC PREVALENCE OF CHRONIC DISEASES IN THE UNITED STATES
Patel, J. G. / Shah, A. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. L. | 2011
A70
PSY64 GE CENTRICITY® ELECTRONIC MEDICAL RECORDS STUDY: COMORBIDITIES AND BIOLOGIC EXPERIENCE AMONG PATIENTS RECEIVING GOLIMUMAB
Tandon, N. / Carter, C. / Haas, S. / Gunnarsson, C. | 2011
A71
PSY70 ASSOCIATION OF PROVIDER CONTINUITY WITH HOSPITALIZATION AMONG FLORIDA MEDICAID ENROLLEES WITH SICKLE CELL DISEASE (SCD)
Ma, Q. / Kauf, T. / Hall, A. G. | 2011
A72
PSY75 PREVALENCE RATIOS AGAINST ODDS RATIOS AS EFFECT MEASURES IN A CROSS-SECTIONAL STUDY OF OBESITY AND ITS CHRONIC COMORBID CONDITIONS
Patel, J. G. / Rajan, S. S. / Aparasu, R. R. / Johnson, M. | 2011
A73
PSY80 PRIORITIZATION AND WEIGHTING OF PATIENT-RELEVANT ENDPOINTS (PRES) AS PART OF THE IQWIGS EFFICIENCY FRONTIER METHOD IN GERMANY
M&#x00FC / hlbacher, A. / Bridges, J. F. / Bethge, S. / Dintsios, C. M. / Schwalm, A. / N&#x00FC / bling, M. | 2011
A74
PUK4 CUMULATIVE EXPOSURE TO NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS) AND THE PROGRESSION OF CHRONIC KIDNEY DISEASE (CKD)
Yarger, S. / Nwokeji, E. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. | 2011
A76
PUK14 A MARKOV MODEL COMPARING SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR MEDICARE PATIENTS WITH IDIOPATHIC OVERACTIVE BLADDER REFRACTORY TO CONSERVATIVE CARE
Ganz, M. / Clemens, J. Q. / Anger, J. / Denevich, S. / Shah, D. / Carlson, A. / Wittek, M. R. / Pashos, C. | 2011
A77
PUK19 KIT73: PRELIMINARY REPORTS OF IMMUNOSUPRESSANT THERAPY PATTERNS IN A COHORT OF POST KIDNEY TRANSPLANT PATIENTS IN BRAZIL
Carvalho, D. D. / Garcia, V. / Abbud-Filho, M. / Nishikawa, A. M. / Asano, E. / Nita, M. E. / Szabo, S. M. / Levy, A. R. / Carvalho, J. F. / Donato, B. M. | 2011
A78
PUK24 USE OF BIOMARKERS IN PROPENSITY SCORE MATCHING TO MITIGATE CHANNELING BIAS IN A RETROSPECTIVE COHORT OF ESRD PATIENTS
Wilson, S. M. / Rubin, J. L. | 2011
A79
PMD5 OUTCOME STUDY OF DRUG ELUTING STENT (DES) VERSUS BARE METAL STENT (BMS) IN HONG KONG: A 6-MONTH PILOT STUDY
Lee, V. / Yan, B. / Chan, T. / Woo, A. / Lee, K. K. / Yu, C. M. | 2011
A80
PMD11 IDENTIFYING POTENTIAL DRIVERS OF COST SAVINGS WITH INSULIN ADMINISTRATION DEVICES IN TYPE-2 DIABETES IN THE UNITED STATES
Pollock, R. F. / Curtis, B. / Boye, K. S. / Timlin, L. / Valentine, W. J. | 2011
A81
PMD16 COMPARISON OF COST AND CLINICAL OUTCOMES OF OPEN VERSUS LAPAROSCOPIC THORACIC PROCEDURES IN THE UNITED STATES
Hashemi, L. / Minshall, M. E. | 2011
A82
PMD21 IS CYBERKNIFE A COST-EFFECTIVE OPTION FOR TREATING PROSTATE CANCER?
Parthan, A. / Pruttivarasin, N. / Taylor, D. / Davies, D. / Yang, G. / Pawar, V. / Weinstein, M. | 2011
A85
PMD40 METHODOLOGICAL CONSIDERATIONS IN MODELING THE ECONOMIC VALUE OF DIAGNOSTIC ACCURACY
Foley, K. / Lim, S. / Schulman, K. L. | 2011
A86
PSU4 SURGEON'S VOLUME-OUTCOMES RELATIONSHIP FOR LOBECTOMIES AND WEDGE RESECTIONS FOR CANCER USING VIDEO-ASSISTED THORACOSCOPIC TECHNIQUES
David, G. / Gunnarsson, C. / Moore, M. / Howington, J. / Miller, D. / Maddaus, M. / McKenna, R. / Meyers, B. / Swanson, S. | 2011
A87
PSU9 ECONOMIC EVALUATION OF THE CURRENT TREND TOWARDS MORE UNCEMENTED FIXATION IN PRIMARY HIP ARTHROPLASTIES AND THE POTENTIAL IMPACT OF CHANGES OF THE DEVELOPMENT IN ENGLAND AND WALES
Kontekakis, A. / Gaiser, S. | 2011
A88
PSU14 HEALTH-RELATED QUALITY OF LIFE FOR PATIENTS ON KIDNEY TRANSPLANT WAITING LIST - WHAT FACTORS REALLY MATTER?
Ong, S. C. / Chow, W. L. / van der Erf, S. / Joshi, V. D. / Tee, P. S. / Lu, Y. M. / Kee, T. Y. | 2011
A89
PSU20 IS THERE INDICATION BIAS OF RETROSPECTIVE OBSERVATIONAL STUDY?
Choi, J. E. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Lee, N. R. / Joo, C. K. | 2011
A91
PDB6 LONG-TERM EFFECTIVENESS OF MANAGING DIABETES WITH THE CHRONIC CARE MODEL: SIMULATIONS PERFORMED USING ARCHES
Zgibor, J. C. / Kuo, S. / Schuetz, C. A. / Roberts, M. S. / Cohen, M. D. | 2011
A92
PDB11 COMPARISON OF MULTIVARIABLE-ADJUSTED LOGISTIC REGRESSION WITH PROPENSITY SCORE-MATCHED, PROPENSITY SCORE-STRATIFIED, AND PROPENSITY SCORE-ADJUSTED LOGISTIC REGRESSION MODELS
Khoza, S. / Barner, J. C. / Richards, K. | 2011
A94
PDB22 INSULIN GLARGINE PLUS OHAS VERSUS BIPHASIC INSULIN IN TYPE-2 DIABETES – A COST COMPARISON
Tilling, C. / Owens, D. / Keech, M. | 2011
A96
PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADA
Haig, J. / Lawrence, D. / Barbeau, M. / Blouin, J. / Cruess, A. | 2011
A97
PDB37 MAIL-ORDER PHARMACY USE AND MEDICATION ADHERENCE AMONG MEDICARE PART D BENEFICIARIES WITH DIABETES
Zhang, L. / Zakharyan, A. / Stockl, K. M. / Harada, A. S. / Curtis, B. S. / Solow, B. K. | 2011
A98
PDB43 TREATMENT COMPLIANCE TO DIABETES CARE: A CROSS-SECTIONAL STUDY FROM PAKISTAN
Parveen, M. / Piyarali, S. | 2011
A99
PDB48 DO WE KNOW WHAT ARE THEY TRADING OFF? – A FEASIBILITY STUDY TO MEASURE QUALITY OF LIFE IN TAIWANESE TYPE-2 DIABETES OUTPATIENTS BY TIME-TRADE-OFF METHOD
Huang, L. H. / Chen, L. C. / Huang, Y. B. / Hwang, S. J. | 2011
A100
PDB53 PRESCRIBING PATTERN OF ANTIDIABETIC DRUGS IN T2DM PATIENTS TERTIARY CARE HOSPITAL IN INDIA
Raval, A. D. / Dhanaraj, E. / Bhansali, A. | 2011
A101
PDB58 WHAT IS THE IMPACT OF GENERIC SUBSTITUTION OF ROSIGLITAZONE ON PATIENT OUTCOMES AND TREATMENT COSTS? AN HMO EXPERIENCE
Triki, N. / Greenberg, D. / Mossinson, D. / Shani, S. | 2011
A102
PDB64 EVALUATION OF THE BURDEN OF ILLNESS OF TYPE-2 DIABETES MELLITUS IN A MEDICARE POPULATION
Costantino, M. E. / Song, F. / Stacy, J. N. / Aagren, M. / Bouchard, J. / Marrett, E. | 2011
A103
PDB69 EXENATIDE (BID) AND LIRAGLUTIDE (QD) TREATMENT PATTERNS AMONG TYPE-2 DIABETES PATIENTS IN GERMANY
Miller, L. A. / Burudpakdee, C. / Zagar, A. / Bhosle, M. / Reaney, M. / Schabert, V. F. | 2011
A105
PIH4 COMPARATIVE EFFECTIVENESS OF BANKED DONOR MILK FOR PREMATURE INFANTS: EFFICIENCY OF A MILK BANK MODEL INTEGRATED IN A BLOOD BANK SETTING
Richer, E. / Dourdin, N. / Goetghebeur, M. | 2011
A106
PIH9 COSTS TO THE NATIONAL HEALTH INSURACE SCHEME OF THE FREE MATERNAL HEALTH SERVICE CHALLENGES AND IMPLICATIONS FOR SUSTAINABILITY IN GHANA
Odame, E. | 2011
A108
PIH20 ECONOMIC EVALUATION OF THE USE OF EXOGENOUS PULMONARY SURFACTANTS IN PRETERM NEWBORNS WITH RESPIRATORY DISTRESS SYNDROME IN MEXICAN POPULATION COVERED BY THE NEW GENERATION MEDICAL INSURANCE
Salinas Escudero, G. / Martinez Valverde, S. / Villasis Keever, M. A. / Gardu&#x00F1 / o Espinosa, J. / Reyes L&#x00F3 / pez, A. / Mu&#x00F1 / oz Hern&#x00E1 / ndez, O. | 2011
A109
PIH25 IMPACT OF PATIENT BEHAVIORS AND ATTITUDES ON TERIPARATIDE ADHERENCE IN A MEDICARE PART D POPULATION
Foster, S. / Hazel-Fernandez, L. A. / Uribe, C. / Song, F. / Thomas, N. / Burge, R. T. / Krohn, K. | 2011
A111
PIH37 DUAL VETERAN HEALTH ADMINISTRATION AND MEDICARE USE AND AMBULATORY CARE SENSITIVE HOSPITALIZATIONS
Ajmera, M. R. / Wilkins, T. L. / Sambamoorthi, U. | 2011
A112
PIH42 A NET BENEFIT FRAMEWORK (NBF) ANALYSIS OF CHART DATA FOR HAEMOPHILIA INHIBITOR PATIENTS
Weatherall, J. / Mesterton, J. / Lindgren, P. / Dalen, J. | 2011
A113
PIN1 VACCINE-ASSOCIATED GUILLAIN-BARRE SYNDROME: A PHARMACOVIGILANCE ANALYSIS OF DATA IN THE UNITED STATES' VACCINE ADVERSE EVENT REPORTING SYSTEM (1990-2009)
Ali, A. K. | 2011
A114
PIN6 TRENDS OF HEPATITIS A INCIDENCE FROM 2005 TO 2008
Eisenberg, D. / Changolkar, A. K. / Misurski, D. A. | 2011
A116
PIN17 TREATMENT PATTERNS AND DRUG TREATMENT COSTS ASSOCIATED WITH NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR (NNRTI)-BASED ANTIRETROVIRAL THERAPY IN TREATMENT-NAÏVE HIV-1 INFECTED PATIENTS
Diels, J. / Langham, S. / Nuyts, G. / Adriaenssen, I. | 2011
A117
PIN23 COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR (ATV+RTV) COMPARED WITH LOPINAVIR/RITONAVIR (LPV+RTV) IN TREATMENT-NAÏVE HIV-INFECTED PATIENTS IN MEXICO: A MODEL BASED ON THE CASTLE STUDY
Juarez-Garcia, A. / Martinez-Rivera, G. / Donato, B. M. | 2011
A118
PIN29 A COST-EFFECTIVENESS ANALYSIS ON THE USE OF DAPTOMYCIN FOR THE TREATMENT OF SKIN AND SOFT TISSUE INFECTIONS WITH FAILURE TO VANCOMYCIN THERAPY IN MEXICO
Briones, B. / Martinez Revelles, M. / Garc&#x00ED / a-Contreras, F. | 2011
A119
PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS
Tarride, J. E. / Burke, N. / von Keyserlingk, C. / O'Reilly, D. / Xie, F. / Goeree, R. | 2011
A120
PIN39 IMMUNIZATION BARRIERS AND SUGGESTED SOLUTIONS IN IRAQ
Al-lela, O. Q. / Bahari, M. B. / Alabbassi, M. G. / Basher, A. Y. | 2011
A121
PIN45 IMPACT OF GOVERNMENT SPONSORED POLIO CONTROL PROGRAM ON KNOWLEDGE, ATTITUDE AND PERCEPTION OF POLIO IN GENERAL COMMUNITY OF BAHAWALPUR, PAKISTAN
Atif, M. / Asif, M. / Sulaiman, A. / Saleem, F. / Ahmad, N. / Saqib, N. / Qamar, M. | 2011
A122
PIN52 MAPPING STATE AND FEDERAL IMMUNIZATION RECORDS POLICIES
Hedden, E. / Jessop, A. / Field, R. I. | 2011
A123
PMS4 THE ASSOCIATION BETWEEN TERIPARATIDE PERSISTENCE AND FRACTURE OUTCOMES IN A US CLAIMS DATABASE
Yu, S. / Foster, S. / Burge, R. / Anderson, J. / Gelwicks, S. / Meadows, E. | 2011
A124
PMS11 APPLYING THE STRATIFIED PROPENSITY SCORE MATCHING METHOD WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTS
Baser, O. / Xie, L. | 2011
A125
PMS16 COST OF RHEUMATOID ARTHRITIS PATIENTS RECEIVING TNF-ANTAGONIST THERAPY FROM THE KOREA NATIONAL HEALTH INSURANCE CLAIMS DATABASE
Park, S. J. / Lee, E. K. | 2011
A126
PMS21 ABATACEPT OR INFLIXIMAB FOR RHEUMATOID ARTHRITIS IN VENEZUELA? A COST-EFFECTIVENESS ANALYSIS
Alfonso-Cristancho, R. / Serra, N. / Aiello, E. C. / Roa, C. N. | 2011
A127
PMS26 COST-EFFECTIVENESS MODELING IN OSTEOPOROSIS: A SYSTEMATIC LITERATURE REVIEW AND OVERVIEW
Smolen, H. J. / Myers, J. A. / Smolen, L. J. | 2011
A128
PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAIN
van der Velde, G. / Hincapi&#x00E9 / C. / Schieir, O. / Cot&#x00E9 / P. / Hogg-Johnson, S. / Paulden, M. / Krahn, M. | 2011
A129
PMS37 INDIRECT COMPARISON OF ADALIMUMAB VERSUS ETANERCEPT FOR THE TREATMENT OF PSORIATIC ARTHRITIS
Kirson, N. / Rao, S. / Birnbaum, H. G. / Kantor, E. / Wei, R. / Cifaldi, M. | 2011
A130
PMS42 CONTENT VALIDITY AND HEALTH CARE SYSTEMS: A CASE-STUDY
Gagol, G. / Fernandez, N. / Rouanet, S. | 2011
A131
PMS47 EMPLOYABILITY-ADJUSTED-LIFE-YEARS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH GOLIMUMAB PLUS METHOTREXATE OR METHOTREXATE ALONE
Han, C. / Gathany, T. / Tandon, N. / Hsia, E. | 2011
A136
PRS1 SEVERE ASTHMA EXACERBATIONS ASSOCIATED WITH LONG-ACTING BETA AGONISTS AMONG CHILDREN AND ADOLESCENTS WITH ASTHMA
Guo, J. J. / Tsai, K. / Kelton, C. / Bian, B. / Wigle, P. | 2011
A137
PRS6 WATERPIPE SMOKING AMONG JORDANIAN ADULTS: PREDICTORS AND CORRELATES
Yang, M. / Abughosh, S. / Wu, I. H. / Sansgiry, S. / Peters, R. J. / Hawari, F. I. / Essien, E. J. | 2011
A138
PRS12 A NATIONAL SURVEY OF SOCIETAL COST OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN SOUTH KOREA
Kim, J. / Park, S. / Kim, Y. / Lee, E. / Oh, Y. / Boo, Y. | 2011
A139
PRS17 COST EFFECTIVENESS OF TOP 20 HIGHEST SELLING DRUGS
Aggarwal, S. | 2011
A140
PRS22 COPD MAINTENANCE MEDICATION ADHERENCE: INFLUENCE ON HOSPITALIZATION AND SPENDING IN A MEDICARE POPULATION
Simoni-Wastila, L. / Wei, Y. J. / Qian, J. / Zuckerman, I. H. / Stuart, B. / Shaffer, T. / Dalal, A. / Bryant-Comstock, L. | 2011
A141
PRS27 THE DEVELOPMENT OF A PATIENT-REPORTED OUTCOME INSTRUMENT TO EVALUATE NIGHTTIME SYMPTOMS OF COPD
Palsgrove, A. / Schaefer, M. / Hareendran, A. / Houghton, K. / Mocarski, M. / Carson, R. / Make, B. | 2011
A143
PRS38 EFFECT OF HAVING A PRESCRIPTION DRUG PLAN ON ASTHMA PATIENTS' USE OF CONTROLLER MEDICATIONS
Vaidya, V. / Peeters, M. / Partha, G. / Potnis, P. | 2011
A144
PRS43 REGRESSION VERSUS PROPENSITY MATCHING AS OUTCOME ANALYSIS ADJUSTMENT METHODS: EXAMPLE USING COPD INITIAL THERAPIES
Roberts, M. / Dalal, A. A. | 2011
A145
PRM2 MEASURING DRUG THERAPY GUIDELINES ON OUTCOMES: A TUTORIAL
Baser, O. | 2011
A146
PRM8 LEGAL RESTRICTIONS ON THE USE OF QALYS IN PHARMACOECONOMIC ANALYSIS IN GERMANY
Gissel, C. / Goetz, G. / Repp, H. | 2011
A147
PRM13 COMPARISON OF DISCRETE EVENTS SIMULATION SOFTWARE FOR USE IN HEALTH ECONOMICS & OUTCOMES RESEARCH
Anaya, P. | 2011
A148
PRM18 CAN UTILITIES EXCEED 1.0? EMPIRICAL EVIDENCE OF THE CEILING EFFECT
Sullivan, P. W. / Ghushchyan, V. H. | 2011
A150
PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS
Perampaladas, K. / Doble, B. M. / Xie, F. | 2011
A151
PRM35 DEVELOPMENT OF A CONCEPT LIST TO ENSURE COMPARABLE CONTENT VALIDITY BETWEEN ORIGINAL PRO QUESTIONNAIRES AND THEIR TRANSLATIONS: A REVIEW OF 15 YEARS OF LINGUISTIC VALIDATIONS
Mear, I. / Conway, K. | 2011
A152
PRM40 ISSUES CONCERNING THE TRANSLATION OF THE WORD ‘HASSLED' IN THE MORISKY MEDICATION ADHERENCE SCALE (MMAS-8)
Griffin, A. / Wild, D. / Morisky, D. E. | 2011
A153
PRM46 R … YOU AWARE HOW USEFUL IT IS? THE VALUE OF CORRELATION COEFFICIENTS IN META-ANALYSIS
Al-Dakkak, I. / Patel, S. / Jen, M. H. / von Maltzahn, R. | 2011
A154
PCN2 SAFETY AND TREATMENT PATTERNS OF ANGIOGENESIS INHIBITORS IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) IN THE UNITED KINGDOM: PRELIMINARY RESULTS OF AN ONGOING CHARTS REVIEW STUDY
Hawkins, R. / Wagstaff, J. / Nathan, P. / Sarda, S. P. / Vekeman, F. / Korves, C. / Dasgupta, S. / O'Mara, S. / Fitton, S. / Hayers, J. | 2011
A156
PCN12 RESOURCE UTILIZATION AND PERCEPTIONS OF MAJOR MOLECULAR RESPONSE IN CHRONIC MYELOID LEUKEMIA (CML): RESULTS OF A DELPHI PANEL STUDY
Bollu, V. / Quintas-Cardama, A. / Flamm, M. / Lill, M. / Thirman, M. / Ravandi-Kashani, F. / Akard, L. / Talpaz, M. | 2011
A158
PCN23 IMPACT OF US FOOD AND DRUG ADMINISTRATION'S BLACK BOX WARNINGS ON ADVERSE EVENTS REPORTING RATES FOR MULTIPLE MYELOMA DRUGS
Garg, V. / Raisch, D. W. / Mckoy, J. / Trifilio, S. / Holbrook, J. / Samaras, A. T. / West, D. | 2011
A159
PCN28 COST SAVINGS WITH FERRIC CARBOXYMALTOSE THROUGH ITS IMPACT ON ERYTHROPOÏESIS-STIMULATING AGENTS AND BLOOD TRANSFUSION IN CHEMOTHERAPY-INDUCED ANEMIA OF BREAST AND GASTROINTESTINAL CANCER: FRENCH HEALTH CARE PAYER PERSPECTIVE
Luporsi, E. / Mahi, L. / Moore, C. / Wernli, J. / Bugat, R. | 2011
A160
PCN34 LONG-TERM DIRECT MEDICAL COSTS IN PATIENTS DIAGNOSED WITH FOLLICULAR LYMPHOMA WHO RECEIVE FRONTLINE CHEMOTHERAPY WITH VERSUS WITHOUT RITUXIMAB - A SEER MEDICARE ANALYSIS
Griffiths, R. I. / Gleeson, M. L. / Mikhael, J. R. / Danese, M. D. | 2011
A161
PCN39 COSTS AT THE END OF LIFE FOR PATIENTS WITH CASTRATION-RESISTANT PROSTATE CANCER (CRPC)
Alemayehu, B. / Parry, D. / Engel-Nitz, N. M. / Kulakodlu, M. / Nathan, F. | 2011
A162
PCN46 HEALTH CARE EXPENDITURES, DISABILITY DAYS, AND RESOURCE UTILIZATION ASSOCIATED WITH CANCER IN EMPLOYER SETTINGS IN THE UNITED STATES
Tang, D. / Alberts, D. S. / Nevins, R. / Sullivan, S. / Skrepnek, G. H. | 2011
A164
PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?
Djalalov, S. / Beca, J. / Hoch, J. | 2011
A166
PCN68 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB REISTANT PATIENTS WITH CHRONIC MYELOGENOUS LEUKAEMIA
Taylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. | 2011
A167
PCN73 UTILISATION OF ANTINEOPLASTIC AGENTS IN SLOVAK REPUBLIC
Gatialova, K. / Bellova, K. / Petrova, L. / Majtas, J. / Binder, R. | 2011
A168
PCN79 IMPACT OF NON-ADHERENCE TO IMATINIB ON PROGRESSION-FREE SURVIVAL AS 1ST TREATMENT FOR CHRONIC MYELOID LEUKEMIA IN BRAZIL: TWO YEARS FOLLOW UP
Funke, V. A. / Moellmann-Coelho, A. / Asano, E. / Nita, M. E. / Donato, B. M. / Rahal, E. | 2011
A169
PCN84 PATIENTS' PREFERENCES FOR THE TREATMENT OF COLORECTAL CANCER: A DISCRETE CHOICE EXPERIMENT (DCE) SURVEY
Albassam, A. / Noyce, P. / Ashcroft, D. | 2011
A170
PCN89 HTA AGENCIES' PREFERENCES REGARDING QUALITY OF LIFE MEASURES FOR PROSTATE CANCER CLINICAL TRIALS
Peeters, P. / Casamayor, M. / Mo&#x00EF / se, P. / Holmstrom, S. | 2011
A172
PCN101 HEALTH CARE RESOURCE UTILIZATION AND ECONOMIC BURDEN OF METASTATIC AND RECURRENT LOCALLY-ADVANCED HEAD AND NECK CANCER PATIENTS
Le, T. K. / Winfree, K. B. / Yang, H. / Marynchenko, M. / Yu, A. P. / Frois, C. / Wu, E. Q. | 2011
A173
PCN106 RESEARCH ON THE FACTORS AFFECTING THE ADOPTION OF HIGH VALUE MEDICAL CONSUMES IN LESS DEVELOPED AREAS OF CHINA
Jing, W. / Guanglian, X. | 2011
A175
PCN117 ASSOCIATION OF HEALTH-RELATED QUALITY OF LIFE (HRQOL) WITH ISS STAGE AND ECOG STATUS IN MULTIPLE MYELOMA
Pashos, C. L. / Durie, B. G. / Mehta, J. / Toomey, K. / Terebelo, H. R. / Abonour, R. / Fonseca, R. / Gasparetto, C. / Narang, M. / Rifkin, R. M. | 2011
A176
PCN121 ONCOLOGY MEDICATION UTILIZATION BASED ON FEDERAL DRUG ADMINISTRATION (FDA) LABELING, NATIONAL COMPREHENSIVE CANCER NETWORK (NCCN) CLINICAL PRACTICE GUIDELINE (GL) RECOMMENDATIONS, AND EVIDENCE FOR PATIENTS WITH ADVANCED NON SMALL CELL LUNG CANCER (NSCLC): AN ANALYSIS FROM THE NCCN ONCOLOGY OUTCOMES DATABASE
Lepisto, E. M. / Vandergrift, J. L. / Kalemkerian, G. P. / Pisters, K. M. / Zornosa, C. / Rabin, M. S. / Reid, M. E. / Koczywas, M. / Otterson, G. A. / Ettinger, D. S. | 2011
A177
PCN126 OVERVIEW OF PRIMARY ENDPOINTS, PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) FOR NON-SMALL CELL LUNG CANCER (NSCLC): THEIR VALUE IN TREATMENT DECISIONS AND PATIENT CARE
Heron, L. / De Castro Carpe&#x00F1 / o, J. / Chouaid, C. / Vergnen&#x00E8 / gre, A. / Bischoff, H. G. / Walzer, S. | 2011
A178
PCN131 REPRESENTING UNCERTAINTY IN CALIBRATED CANCER TREATMENT MODELS: A PRACTICAL APPROACH
Taylor, D. C. / Leahy, K. J. / Weinstein, M. | 2011
A179
PCN137 COMPREHENSIVE REVIEW OF MANAGEMENT EFFICIENCY STRATEGIES AMONG ONCOLOGY PRACTICES: EXISTING EVIDENCE AND OPPORTUNITIES FOR FUTURE RESEARCH
Gorman, K. / Miller, R. / McGarvey, N. / Corey-Lisle, P. | 2011
A180
PGI4 PREDICTORS OF HEPATITIS C TREATMENT INITIATION
Wagner, J. S. / Goren, A. | 2011
A181
PGI9 COMPARISON OF DIRECT MEDICAL COSTS AND SERVICES BY POINT OF SERVICE AND PRESCRIPTION COST FOR PERSONS WITH HEPATITIS-C WITH AND WITHOUT TREATMENT
Brook, R. A. / Kleinman, N. L. / Smeeding, J. | 2011
A183
PGI20 IBS-C PATIENT SYMPTOM REPORTS: ANALYSIS OF EXPLORATORY OPEN-ENDED QUESTIONS
Carson, R. T. / Lewis, B. E. / Shiff, S. J. / Johnston, J. M. / Dennee-Sommers, B. / Lasch, K. E. / Hwang, S. / Marquis, P. | 2011
A185
PMH3 RISK OF HIP FRACTURES IN ELDERLY MEDICARE BENEFICIARIES USING ATYPICAL OR TYPICAL ANTIPSYCHOTICS: A PROPENSITY SCORE ANALYSIS
Dharmarajan, S. H. / Yang, Y. / Athavale, A. S. / Bentley, J. P. / Null, K. D. / Banahan, B. F. | 2011
A186
PMH9 RISK OF DEATH IN DUAL ELIGIBLE NURSING HOME RESIDENTS USING ANTIPSYCHOTIC AGENTS
Aparasu, R. R. / Mehta, S. / Chen, H. | 2011
A187
PMH14 CLINICAL EFFECTIVENESS ANALYSIS OF NALTREXONE VERSUS ACAMPROSATE AND PLACEBO IN ALCOHOL DEPENDENT PATIENTS TREATED WITH PSYCHOTHERAPY
Jarosz, J. / Miernik, K. / Wachal, M. / Walczak, J. | 2011
A188
PMH19 THE BUDGET IMPACT ANALYSIS OF NALTREXONE IN THE TREATMENT OF ALCOHOL-DEPENDENT PATIENTS IN POLAND
Walczak, J. / Semeniuk, A. / Pacocha, K. / Nogas, G. | 2011
A189
PMH24 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH PHARMACOLOGICAL AND NON-PHARMACOLOGICAL SUBSTANCE MEDICATIONS FOR ALCOHOL DEPENDENCY
Baser, O. / Wang, L. / Xie, L. | 2011
A190
PMH29 ESTIMATION OF DIRECT COSTS OF TREATING SCHIZOPHRENIA FOR COMMUNITY-DWELLING UNITED STATES RESIDENTS
Desai, P. / Lawson, K. / Barner, J. C. / Rascati, K. L. | 2011
A191
PMH35 COMPARISONS OF MENTAL HEALTH-RELATED MEDICAL CARE UTILIZATION AND COSTS FOLLOWING THE INITIATION OF ORAL VERSUS LONG-ACTING INJECTABLE RISPERIDONE IN PATIENTS WITH SCHIZOPHRENIA
Park, H. / Kim, D. N. / Rascati, K. L. | 2011
A192
PMH40 COST-EFFECTIVENESS AND BUDGET IMPACT OF ADJUNCT QUETIAPINE FUMARATE EXTENDED-RELEASE IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER WITH AN INADEQUATE RESPONSE TO PREVIOUS THERAPY
Svedsater, H. / Locklear, J. / Johal, S. / Stillman, I. O. | 2011
A193
PMH45 MEASURES OF MEDICATION ADHERENCE IN ORAL VERSUS LONG-ACTING RISPERIDONE IN TEXAS MEDICAID PATIENTS WITH SCHIZOPHRENIA
Kim, D. N. / Park, H. / Rascati, K. L. | 2011
A194
PMH50 A TIME-TRADE-OFF STUDY OF HEALTH-RELATED QUALITY OF LIFE ADVANTAGE OF LONG-ACTING INJECTABLE ANTIPSYCHOTIC TREATMENT FOR SCHIZOPHRENIA
Osborne, R. H. / Dalton, A. / Hertel, J. / Schrover, R. / Kingsford Smith, D. | 2011
A195
PMH55 THE BURDEN OF DIAGNOSED DEPRESSION AND SLEEP DIFFICULTIES ON QUALITY OF LIFE, WORK PRODUCTIVITY, AND RESOURCE USE
Gupta, S. / Goren, A. / Gabriel, S. / Kim, E. / Dupclay, L. | 2011
A196
PMH60 BIPOLAR DISORDER RESULTS IN SIGNIFICANT BURDEN ON CAREGIVERS: ANALYSIS OF DATA FROM A LARGE MULTINATIONAL LONGITUDINAL STUDY (WAVE-BD)
Vieta, E. / Figueira, M. L. / Bellivier, F. / Souery, D. / Blasco-Colmenares, E. / Langosch, J. M. / Medina, E. | 2011
A197
PMH65 EFFECT OF PRESCRIPTION MONITORING PROGRAMS (PMP'S) ON OPIOID OVERDOSE ADMISSION
Painter, J. T. | 2011
A199
PMH76 PHARMACIST AND PHARMACY STAFF KNOWLEDGE AND ATTITUDES TOWARDS SUICIDE AND SUICIDE PREVENTION AFTER A NATIONAL VA TRAINING PROGRAM
Lavigne, J. E. / King, D. A. / Lu, N. / Knox, K. L. / Kemp, J. E. | 2011
A200
PMH81 RELATIONSHIP BETWEEN ADHERENCE TO ANTIDEPRESSANT TREATMENTS AND DEPRESSIVE RELAPSE
Jung, S. Y. / Shin, S. / Song, H. / Park, J. / Ahn, J. | 2011
A201
PND1 PRESCRIBING PATTERNS OF DRUGS HAVING ANTICHOLINERGIC ACTIVITY IN PATIENTS WITH ALZHEIMER'S DISEASE
Gala, S. D. / Gupte, K. P. / Wu, W. K. | 2011
A202
PND6 THE IMPACT OF SPECIALTY CARE PROGRAMS ON RELAPSES OF MULTIPLE SCLEROSIS USING ADMINISTRATIVE DATA
Tang, J. / Levin, M. C. / Bailey, J. E. / Faris, R. J. / Hong, S. H. / Chang, C. F. / Wang, J. | 2011
A203
PND11 THE ECONOMIC BURDEN OF OSA IN EACH OF THE METABOLIC SYNDROME COMPONENTS LEVELS
Greenberg-Dotan, S. / Yan, X. / Scharf, S. M. / Shaya, F. T. | 2011
A206
PND27 MEDICO-ECONOMIC EVALUATION OF LACOSAMIDE ADJUNCTIVE THERAPY IN THE TREATMENT OF PATIENTS WITH REFRACTORY EPILEPSY IN THE UNITED STATES
Benhaddi, H. / Helmers, S. | 2011
A207
PND32 HEALTH RESOURCE UTILIZATION AND COSTS FOR MIGRANEURS IN SCOTLAND
Bloudek, L. M. / Hansen, R. N. / Liu, L. / Batty, A. J. / Varon, S. F. / Lipton, R. B. / Sullivan, S. D. | 2011
A208
PND38 THE HIDDEN TOLL OF CAREGIVER BURDEN IN MULTIPLE SCLEROSIS
Stewart, M. / Phillips, A. / Edwards, N. / Gupta, S. / Goren, A. | 2011
A209
PND43 THE PATIENTSLIKEME® EPILEPSY COMMUNITY: A UNIQUE INSIGHT INTO THE LIVES OF PATIENTS WITH EPILEPSY
de la Loge, C. / Dimova, S. / Massagli, M. / Wicks, P. | 2011
A210
PND48 MEASUREMENT CHARACTERISTICS OF THE SF-36 IN CHRONIC NEUROMUSCULAR DISORDER
Banks, P. / Martin, C. R. / Petty, R. | 2011
A211
PND54 RETROSPECTIVE DATABASE ANALYSIS OF FREQUENCY AND COSTS OF RELAPSES AMONG MULTIPLE SCLEROSIS PATIENTS
Boklage, S. / Preblick, R. / Yaldo, A. / Golick, M. / Pocoski, J. | 2011
A212
PND59 MEDICATION TREATMENT PATTERNS FOR MULTIPLE SCLEROSIS PATIENTS IN THE BRAZILIAN PUBLIC HEALTH CARE SYSTEM
Takemoto, M. M. / Takemoto, M. L. / Fernandes, R. A. / Duarte, G. G. / Moretti, A. I. / Santos, P. M. / Tolentino, A. C. | 2011
A213
PND64 APPLICATION OF PREDICTIVE MODELING TO CLASSIFY FREQUENT SNORING IDENTIFIED FROM ROUTINE MEDICAL EXAMINATIONS USING THE NHANES DATABASE
Row, B. | 2011
A215
ISPOR 16th Annual International Meeting Financial Disclosure Information for Research Presentations
| 2011
A223
ISPOR 16TH Annual International Meeting Research Abstracts Author Index
| 2011
i
Table of Contents
| 2011
PHP99 WILL BIOPHARMACEUTICAL INNOVATION STILL BE A PICTURE OF HEALTH AFTER IMPLEMENTATION OF HEALTH CARE REFORM?
Ross, K. D. | 2011
PCV89 COMPARISON OF DOSING PATTERNS AMONG PATIENTS INITIATING STATIN THERAPY IN A MANAGED CARE POPULATION
Zhao, Z. / Peng, X. / Bae, J. P. / Dungey, J. / Faries, D. E. / Sponseller, C. A. / Wetmore, S. / Yu, C. Y. / LeNarz, L. A. | 2011
PCV97 IS CARDIOVASCULAR MEDICATION USAGE A MARKER FOR CARDIOVASCULAR RISK? POTENTIAL IMPLICATION FOR SMART-EDIT FORMULARY MANAGEMENT STRATEGIES
Hunter, T. D. / Gunnarsson, C. / Bullano, M. F. / de Vane, P. J. | 2011
PDB12 USE OF ANTIDEPRESSANTS AND THE RISK OF DIABETES MELLITUS: A NESTED CASE-CONTROL STUDY
Khoza, S. / Barner, J. C. / Lawson, K. / Rascati, K. L. / Wilson, J. P. / Bohman, T. M. | 2011
PDB60 EFFECT OF MEDICARE PART D COVERAGE GAP ON MEDICATION CONSUMPTION BEHAVIORS: CASE OF ORAL ANTI-DIABETIC MEDICATIONS
Mahabaleshwarkar, R. / Banahan, B. F. | 2011
PMS35 COST UTILITY ANALISYS OF CHONDROITIN SULPHATE(CS) IN THE TREATMENT OF OSTEOARTHRITIS (OA) OF THE KNEE IN MEXICAN PATIENTS
Soto-Molina, H. / Rizzoli-Cordoba, A. / Pizarro-Castellanos, M. / Delgado-Ginebra, I. / Tellez-Giron, G. | 2011
PRS25 FACTORS INFLUENCING SATISFACTION WITH COPD MAINTENANCE MEDICATION: CONCEPTS ELICITED THROUGH QUALITATIVE INTERVIEWS WITH PATIENTS
Mocarski, M. / Palsgrove, A. / Schaefer, M. / Setyawan, J. / Wilcox, T. | 2011
PMS17 EVALUATING THE ASSOCIATION BETWEEN SERUM URIC ACID LEVEL AND HEALTH CARE COSTS IN PATIENTS WITH GOUT
Cheng, I. N. / Duffin, M. / Pulicharam, J. S. / Tong, G. / Aranda, G. A. | 2011
PMS74 PILOT VALIDATION OF THE BRIEF PAIN INVENTORY ‘PAIN AT ITS WORST’ ITEM IN PATIENTS WITH RHEUMATOID ARTHRITIS
Sterling, K. / Naegeli, A. N. / Zagar, A. | 2011
PRM21 CONVERTING PAPER VERSIONS OF PATIENT REPORTED OUTCOME INSTRUMENTS TO ELECTRONIC VERSIONS: IDENTIFYING THE REQUIRED STEPS
Ross, J. / O'Gorman, H. J. / Peck, R. / Ross, E. | 2011
PSY65 CHARACTERISTICS OF GOLIMUMAB UTILIZATION IN A LARGE NATIONAL PAYER DATABASE
Tandon, N. / Saulnier, A. / Gunnarsson, C. | 2011
PSY44 PAIN MANAGEMENT: IMPACT ON QUALITY OF LIFE
Bertin, P. / Rahhali, N. / Auges, M. / Taieb, C. | 2011
PSY60 ECONOMIC CONSEQUENCES OF UNDER-UTILIZATION WITH TUMOR NECROSIS FACTOR INHIBITORS IN RHEUMATOID ARTHRITIS PATIENTS
Carter, C. / Gunnarsson, C. / Rizzo, J. / Bolge, S. / Ingham, M. | 2011
PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS
Keystone, E. / Fleischmann, R. / Han, C. / Smolen, J. S. / Emery, P. / Genovese, M. / Gathany, T. / Doyle, M. / Hsia, E. | 2011
PMS61 INFLIXIMAB INFUSION PATTERNS IN PATIENTS WITH RHEUMATOID ARTHRITIS ‘NAïVE' TO BIOLOGIC THERAPY: AN ANALYSIS OF A NATIONAL HEALTH PLAN
Schmeichel-Mueller, C. / Tkacz, J. / Ruetsch, C. | 2011
PMS65 RHEUMATOID ARTHRITIS PATIENT EXPERIENCE WITH SELF-INJECTION WITH SUBCUTANEOUS BIOLOGICS
Tandon, N. / Ellis, L. / Bolge, S. / Iqbal, R. / Buck, L. | 2011
PMS69 THE USE OF MIXED TREATMENT COMPARISONS IN NICE TECHNOLOGY APPRAISALS
Brooks-Rooney, C. / Costello, S. / Kusel, J. / Timm, B. | 2011
PMD23 COST-EFFECTIVENESS OF SPECIFIC USE OF THE LANCET BD QUIKHEEL® IN SCREENING PROGRAM OF NEONATAL CONGENITAL HYPOTHYROIDISM IN MEXICO
Vallejos Par&#x00E1 / s, A. / Contreras, I. / Ojeda M&#x00E9 / ndez, J. / Yam Ontiveros, C. | 2011
PMD37 A NATIONAL STUDY OF OUT-OF-POCKET EXPENDITURES FOR MAMMOGRAPHY SCREENING
LeMasters, T. / Sambamoorthi, U. | 2011
PRS46 MEASUREMENT COMPARABILITY BETWEEN PAPER AND ALTERNATE VERSIONS: RECOMMENDED ASSESSMENT STEPS USING THE LUNG FUNCTION QUESTIONNAIRE AS AN EXAMPLE
Dalal, A. A. / Nelson, L. M. / Gilligan, T. / McLeod, L. D. / Lewis, S. / DeMuro, C. | 2011
PDB30 A CROSS-SECTIONAL SURVEY ON ECONOMIC BURDEN OF TYPE-2 DIABETES MELLITUS PATIENTS WITH ORAL ANTI-DIABETIC DRUGS THERAPY IN CHINA
Ji, L. / Ye, Q. / Chang, J. H. / Liu, G. G. | 2011
PIH43 METHODOLOGY TO IDENTIFY IN-VITRO FERTILIZATION PATIENTS USING A NATIONAL MANAGED CARE DATABASE
Kozma, C. / Fincher, C. / Hubbard, J. / Meletiche, D. M. | 2011
PCN102 SYNCHRONIZATION OF ADMINISTRATIONS OF CHEMOTHERAPY AND ERYTHROPOIESIS-STIMULATING AGENTS AND FREQUENCY OF ASSOCIATED HEALTH CARE VISITS
Hill, J. / Shreay, S. / McGarvey, N. / De, A. P. / Hess, G. P. / Corey-Lisle, P. | 2011
PCN103 THE IMPACT OF INFUSION REACTIONS ASSOCIATED WITH MONOCLONAL ANTIBODIES IN METASTATIC COLORECTAL CANCER: A EUROPEAN PERSPECTIVE
Chadda, S. / Larkin, M. / Jones, C. / Sykes, D. / Barber, B. / Zhao, Z. / Gao, S. / Bengttson, N. O. | 2011
PCN111 ANALYSIS OF HEALTH OUTCOMES IN BREAST CANCER PATIENTS USING CLUSTER ANALYSIS
Ugiliweneza, B. | 2011
PCV83 GAPS AND UNMET NEEDS IN ANTIPLATELET THERAPIES FOR ACUTE CORONARY SYNDROME (ACS) AND CHRONIC CORONARY HEART DISEASE (CHD)
Lian, J. / Azmi, S. / Navaratnam, P. | 2011
PCV105 THE INITIATION AND EXTENT OF DOSE TITRATION OF ACE INHIBITORS AND β-BLOCKERS POST ACUTE MYOCARDIAL INFARCTION: A PROSPECTIVE AUDIT
Alowayesh, M. S. / Wright, P. | 2011
PRM43 BIOSIMILARS: DEMONSTRATING SIMILARITY THROUGH EVIDENCE
Kleintjens, J. / Dahal, D. / Mai, J. C. / Doyle, J. J. | 2011
PCV2 THE RISK OF CARDIOVASCULAR EVENTS ASSOCIATED WITH DIETARY CALCIUM AND VITAMIN D SUPPLEMENTS IN PATIENTS WITH OSTEOPOROSIS
Chang, J. Y. / Nichol, M. B. | 2011
PCV4 TREATMENT PATTERNS, CLINICAL AND ECONOMIC BURDEN OF VENOUS THROMBOEMBOLISM IN ABDOMINAL SURGERY PATIENTS
Wang, L. / Dysinger, A. H. / Du, J. / Xie, L. / Baser, O. | 2011
PIN2 HEALTH OUTCOMES OF CLINICALLY RELEVANT PATIENT POPULATIONS TREATED WITH DAPTOMYCIN FOR METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS (MRSA) SKIN INFECTIONS
McKinnon, P. S. / Goff, D. A. / Boening, A. J. / Lodise, T. A. | 2011
PCV19 A BAYESIAN MULTIPLE TREATMENT COMPARISON OF PULMONARY ARTERIAL HYPERTENSION DRUG CLASSES BASED ON THE RISK OF MORTALITY REPORTED IN CLINICAL TRIALS
Mutebi, A. / Malone, D. | 2011
PSY7 A NOVEL MECHANISM OF CAPTURING POST-MARKETING SAFETY INFORMATION ON RECOMBINANT FACTOR VIIA (RFVIIA) IN THE RARE DISORDER ACQUIRED HEMOPHILIA: THE ACQUIRED HEMOPHILIA SURVEILLANCE (AHS) PROJECT
Lentz, S. / Tandra, A. / Doucette, K. / Cooper, D. L. | 2011
PMH31 TRAJECTORY ANALYSIS OF HEALTH CARE COSTS FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH HIGH DOSES OF DULOXETINE
Cui, Z. / Faries, D. / Zhao, Y. / Niu, L. / Novick, D. / Liu, X. | 2011
PGI2 PREDICTORS OF PROTON PUMP INHIBITOR (PPI) DOSING REGIMEN AMONG PATIENTS WITH GASTROESOPHAGEAL REFLUX DISEASE (GERD)
Eisenberg, D. / Mody, R. / Singer, J. / Kamat, S. A. / Gerson, L. B. | 2011
PGI23 WORK PRODUCTIVITY AMONG GENOTYPE 1 HEPATITIS C VIRUS (HCV) TREATMENT-NAÏVE PATIENTS RECEIVING TELAPREVIR-BASED TREATMENT REGIMENS: RESULTS FROM ADVANCE AND ILLUMINATE STUDIES
Thal, G. / Nuyts, G. / Mcallister, S. / Luo, D. / Muir, A. J. / Sherman, K. E. / Adda, N. / Wright, C. / Beumont, M. / Gavart, S. | 2011
PMH28 REAL-WORLD HEALTH CARE UTILIZATION AND COSTS IN NEWLY DIAGNOSED DEPRESSION PATIENTS BETWEEN 2006 AND 2008
Schneider, G. / Roy, A. / Busner, J. / Crean, S. / Lanes, S. / Dabbous, O. H. | 2011
PCV101 EXPLORING GENDER DISPARITIES IN PREVENTIVE CARE UTILIZATION AMONGST THE UNITED STATES POPULATION
Vaidya, V. / Partha, G. / Karmakar, M. | 2011
PCV110 DEVELOPMENT AND VALIDATION OF A SHORT PRO MEASURE OF HEALTH STATUS FOR INDIVIDUALS WITH ACUTE MYOCARDIAL INFARCTION: THE MYOCARDIAL INFARCTION DIMENSIONAL ASSESSMENT SCALE (MIDAS)
Jenkinson, C. / Thompson, D. / Roebuck, A. / Churchman, D. | 2011
PCV14 DYSPEPSIA AND DISEASE BURDEN AMONG PATIENTS WITH ATRIAL FIBRILLATION (AF)
LaMori, J. C. / Gross, H. J. / Patel, A. A. / Crain, M. / DiBonaventura, M. D. / Mody, S. H. / Schein, J. | 2011
PSS10 A COST-EFFECTIVENESS ANALYSIS OF ETANERCEPT FOR THE TREATMENT OF MODERATE AND SEVERE PSORIASIS IN MEXICO
Vargas-Valencia, J. / Sotelo-Guzm&#x00E1 / n, M. / Mould-Quevedo, J. F. / Muci&#x00F1 / o-Ortega, E. / Galindo-Suarez, R. M. | 2011
PDB25 COST OF ALL-CAUSE AND CARDIOVASCULAR DISEASE-RELATED HOSPITALIZATION IN PATIENTS WITH TYPE-2 DIABETES TREATED WITH EXENATIDE BID, SULFONYLUREAS, OR INSULIN: A RETROSPECTIVE ANALYSIS OF THE LIFELINK DATABASE
Best, J. H. / Pelletier, E. / Smith, D. B. | 2011
PMS64 PATIENT EXPERIENCE WITH SUBCUTANEOUS ANTI-TNF THERAPY AMONG RHEUMATOID ARTHRITIS PATIENTS
Tandon, N. / Bolge, S. / Annunziata, K. | 2011
PRS37 THE PRICE NEGOTIATION ON PHARMACEUTICALS AFTER THE INTRODUCTION OF POSITIVE LIST SYSTEM IN SOUTH KOREA
Yoon, S. Y. / Lee, E. K. | 2011
PSY3 OPIOIDS IN NON-MALIGNANT PAIN: ARE THEY EQUIVALENT IN SAFETY PROFILE? A NETWORK META-ANALYSIS
Siddiqui, M. K. / Gupta, J. / Bhutani, M. / Sehgal, M. | 2011
PSY39 EPIDEMIOLOGY OF HEREDITARY COAGULOPATHIES IN KAZAKHSTAN: PATIENT-REPORTED DATA
Vorobyev, P. / Borisenko, O. / Zhulyov, Y. / Rybalova, T. / Krasnova, L. / Bezmelnitsyna, L. | 2011
PUK2 DUTASTERIDE FOR BENIGN PROSTATIC HYPERPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Park, T. / Shamliyan, T. A. | 2011
PUK23 METHODOLOGICAL CONSIDERATIONS FOR COST-EFFECTIVENESS ANALYSIS OF ONABOTULINUMTOXINA IN PATIENTS WITH NEUROGENIC DETRUSOR OVERACTIVITY
Globe, D. / Carlson, J. / Patel, H. / Colayco, D. / Hansen, R. N. / Watanabe, J. / Sullivan, S. D. | 2011
PSY14 ECONOMIC IMPACT OF POTENTIAL DRUG-DRUG INTERACTIONS AMONG PATIENTS TAKING OPIOID ANALGESICS
Summers, K. H. / Ohsfeldt, R. / Puenpatom, R. A. / Rajan, N. / Ben-Joseph, R. | 2011
PRM20 TRENDS IN UTILITY ELICITATION METHODS: DIRECT VERSUS INDIRECT METHODS
Prosser, L. A. / Wittenberg, E. | 2011
PDB57 IMPACT OF A PHARMACIST-BASED DIABETES MANAGEMENT PROGRAM ON ADHERENCE TO MEDICATION FOR DIABETIC PATIENTS
Agrawal, R. / Sansgiry, S. / Patel, H. / Hayes, D. / Roberson, K. / James, C. | 2011
PUK16 COST-EFFECTIVENESS OF VALGANCICLOVIR 200 DAYS PROPHYLAXIS VERSUS 100 DAYS PROPHYLAXIS IN KIDNEY TRANSPLANT PATIENTS AT HIGH-RISK FOR DEVELOPING CYTOMEGALOVIRUS DISEASE
Vicente, C. / Humar, A. / Lemieux, C. / Zilbershtein, R. / Douglas, P. / Formica, L. / Piwko, C. | 2011
PMS73 PATIENT-CENTRIC OBSERVATIONAL STUDY ON CORRELATES OF INTENT TO PERSIST WITH TREATMENT: A REGRESSION MODEL IN OSTEOPOROSIS
Horowicz-Mehler, N. / Nixon, M. / Casazza, C. / Gemmen, E. / Doyle, J. / Cascade, E. | 2011
PDB19 ECONOMIC ASSESSMENT OF CONVERSION TO INSULIN PEN DEVICES IN A LONG TERM CARE FACILITY CHAIN
Bazalo, G. / Weiss, R. C. / Bouchard, J. / Perry, R. / Wendt, F. | 2011
PCN18 AN EPIDEMIOLOGICAL MODEL OF PROSTATE CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM
Cure, S. / Martin, M. / Bracco, A. / Brown, J. / Kearney, M. | 2011
PCN20 EXERCISE LOWERS ESTROGEN AND PROGESTERONE LEVELS IN PREMENOPAUSAL WOMEN AT HIGH RISK OF BREAST CANCER
Kossman, D. / Williams, N. / Domchek, S. / Kurzer, M. / Stopfer, J. / Schmitz, K. | 2011
PIN49 A REVIEW OF EPIDEMIOLOGICAL LITERATURE ON THE BASIC REPRODUCTION NUMBER FOR THE 2009 NOVEL STRAIN OF H1N1
Walker, A. / Murphy, J. / Hettle, R. / Plested, M. | 2011
PIN31 COST-EFFECTIVENESS ANALYSIS OF DIFFERENT APPROACHES TO THE DIAGNOSIS AND TREATMENT OF INFLUENZA-LIKE ILLNESS IN HEALTHY ADULTS
Yeh, J. Y. / Budiman, T. A. / Shrestha, N. K. / Gordon, S. M. | 2011
PCN88 ATTITUDES OF YOUNG WOMEN ON HUMAN PAPILLOMA VIRUS VACCINATION
Chopra, P. / Shah, J. / Fase, B. / Sansgiry, S. | 2011
PCN93 ATTACHMENT STYLE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER
Sansgiry, S. / Hart, S. L. / Coon, D. W. / Siffert, K. J. / Latini, D. M. | 2011
PGI24 DOES UTILITY OR CAPABILITY MATTER FOR IRRITABLE BOWEL SYNDROME? - A PRELIMINARY QUALITATIVE STUDY ON TAIWANESE PATIENTS
Hsu, C. C. / Chen, L. C. / Wen, Y. H. / Su, Y. C. | 2011
PCN129 USE OF ELECTRONIC MEDICAL RECORDS (EMR) FOR ONCOLOGY OUTCOMES RESEARCH: ASSESSING THE COMPARABILITY OF EMR INFORMATION TO PATIENT REGISTRY AND HEALTH CLAIMS DATA
Lau, E. L. / Mowat, F. S. / Kelsh, M. A. / Legg, J. / Engel-Nitz, N. M. / Watson, H. N. / Collins, H. / Nordyke, R. J. / Whyte, J. L. | 2011
PND51 THE EFFECT OF THE MEDICARE PART D COVERAGE GAP AND OUT-OF-POCKET BURDEN ON THE USE OF DISEASE MODIFYING DRUGS TO TREAT MULTIPLE SCLEROSIS
Banahan, B. F. / Datar, M. / Mendonca, C. M. / Shahpurwala, Z. / Bentley, J. P. / Phillips, A. L. / Stewart, M. | 2011
PCV41 AN ESTIMATE OF SOCIETAL MONETARY BENEFITS OF SIMVASTATIN IN CANADA
Thanh, N. X. / Chuck, A. / Ohinmaa, A. / Jacobs, P. | 2011
PCV93 HEALTH EXPENDITURE COMPARISON OF METOPROLOL SUCCINATE VS METOPROLOL TARTARATE
Vaidya, V. / Patel, P. | 2011
PCV99 MEDICAL RESOURCE UTILIZATION AND COSTS FOLLOWING HOSPITALIZATION OF PATIENTS WITH CHRONIC HEART FAILURE IN THE UNITED STATES
Korves, C. / Eldar-Lissai, A. / Rodermund, D. / Swallow, E. / Cummings, A. K. / Ariely, R. / Duh, M. S. | 2011
PMD14 COMPARISON OF PER DISCHARGE COSTS OF THE REPAIR OF INCISIONAL/VENTRAL HERNIAS PERFORMED WITH PERMACOL™ AND STRATTICE™ IN THE UNITED STATES
Morseon, M. / Hashemi, L. | 2011
PMD22 COST-EFFECTIVENESS ANALYSIS OF THREE WOUND DRESSINGS FOR THE TREATMENT OF PRESSURE ULCERS FROM THE PUBLIC HOSPITAL PERSPECTIVE
Tolentino, A. C. / Takemoto, M. L. / Fernandes, R. A. / Takemoto, M. M. / Santos, P. M. | 2011
PDB39 A DESCRIPTIVE ANALYSIS OF TREATMENT ADHERENCE WITH GROWTH HORMONE: FINDINGS FROM A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES
Fincher, C. / Kozma, C. / Meletiche, D. M. / Velez, F. | 2011
PMS28 COST-EFFECTIVNESS ANALYSIS OF NSAIDS FOR SYMTOMATIC TREATMENT OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS
Tolubaiev, V. / Zalis'ka, O. | 2011
PCV67 EXAMINING MEDICATION ADHERENCE AMONG TRICARE BENEFICIARIES RECEIVING STATIN THERAPY FOR SECONDARY PREVENTION OF CORONARY HEART DISEASE IN MILITARY TREATMENT FACILITIES IN THE UNITED STATES
Nwokeji, E. / Yarger, S. / Trice, S. / Chao, S. / Devine, J. / Potyk, R. / Gutke, G. / Bonnema, A. | 2011
PMS49 ADOPTION, CHOICE, AND UTILIZATION OF BIOLOGIC THERAPIES FOR RHEUMATOID ARTHRITIS IN THE MEDICARE POPULATION
McElligott, S. / Li, P. / Schwartz, S. / Doshi, J. A. | 2011
PSY51 EFFECTIVENESS OF FDA'S NEW OVER-THE-COUNTER ACETAMINOPHEN LABEL WARNING REQUIREMENTS IN IMPROVING CONSUMER RISK PERCEPTION OF LIVER DAMAGE
Goyal, R. K. / Rajan, S. S. / Essien, E. J. / Sansgiry, S. | 2011
PIH41 SUCCESSFUL SEXUAL INTERCOURSE: TIME-TO-EVENT MODELING IN A SILDENAFIL TRIAL
Cappelleri, J. C. / Bushmakin, A. G. / Stecher, V. / Symonds, T. | 2011
PIN28 ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN BRAZIL USING A TRANSMISSION DYNAMIC MODEL
Singhal, P. K. / Tannus, G. / Fonseca, M. / Kawai, K. / Dasbach, E. | 2011
PCN70 USING PHARMACOECONOMIC MODELING TO DETERMINE A VALUE-BASED PRICE OF NEW CANCER DRUGS IN MALAYSIA
Dranitsaris, G. / Truter, I. / Lubbe, M. / Mahagaonkar, S. | 2011
PCN87 HOW DOES PATIENT-REPORTED OUTCOME DATA INFLUENCE THE CLINICAL DECISION MAKING OF PRACTICING ONCOLOGISTS?
Meldahl, M. L. / Acaster, S. / Hayes, R. P. | 2011
PND52 HEALTH CARE RESOURCE UTILIZATION BEFORE AND AFTER INITIATION OF ARMODAFINIL TREATMENT FOR WAKEFULNESS
Carlton, R. / Regan, T. S. / Lunacsek, O. / Dammerman, R. | 2011
PGI7 THE ECONOMIC BURDEN OF REFRACTORY GERD: A RESTROSPECTIVE CLAIMS DATABASE STUDY
Gerson, L. B. / Bonafede, M. / Princic, N. / Gregory, C. / Farr, A. / Chu, B. C. / Balu, S. | 2011
PGI13 PERCEIVED VALUE ASSESSMENT OF ENTECAVIR VERSUS NO TREATMENT IN CHRONIC HEPATITIS B
Vorobyev, P. / Telegina, I. / Borisenko, O. / Jakouloff, D. | 2011
PMH5 PSYCHIATRIC ADVERSE EFFECTS RELATED TO PRESCRIPTION OF METHYLPHENIDATE IN TAIWAN
Yang, C. L. / Huang, W. F. / Tsai, Y. W. | 2011
PMS12 DIRECT AND INDIRECT COSTS ASSOCIATED WITH DUPUYTREN'S CONTRACTURE
Macaulay, D. / Ivanova, J. / Birnbaum, H. / Sorg, R. / Skodny, P. | 2011
PSY19 THE COST-EFFECTIVENESS OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE VERSUS LENALIDOMIDE PLUS MELPHALAN AND PREDNISONE WITH CONTINUOUS LENALIDOMIDE MAINTENANCE TREATMENT FOR THE INITIAL TREATMENT OF MULTIPLE MYELOMA IN THE UNITED STATES
Wang, S. T. / Huang, H. / Ba-mancini, A. / Shi, H. / Chen, K. / Korves, C. / Dhawan, R. / Cakana, A. / van de Velde, H. / Duh, M. S. | 2011
PDB3 LONG-TERM ANTIPROTEINURIC EFFECT OF ALISKIREN IN DIABETIC PATIENTS WITH PERSISTENT ALBUMINURIA DESPITE CHRONIC ACEI OR ARB TREATMENT
Huang, W. / Mersy, J. H. / Levin, P. | 2011
PDB9 IMPACT OF EXENATIDE, PEN INSULIN AND VIAL/SYRINGE INSULIN ON PATIENT OUTCOMES IN A DIABETES POPULATION IN THE UNITED STATES: A RETROSPECTIVE DATABASE ANALYSIS OF PERSISTENCE AND FIRST-YEAR COSTS
Rashid, N. / McCombs, J. / Foster, S. / Miller, L. A. | 2011
PDB63 GEOGRAPHIC VARIATION IN DRUG SPENDING AND ADHERENCE PATTERNS FOR MEDICARE BENEFICIARIES WITH DIABETES
Shoemaker, J. S. / Dai, M. / Stuart, B. | 2011
PDB65 ECONOMIC BURDEN OF CUSHING'S DISEASE: A POPULATION ANALYSIS OF DIRECT MEDICAL COSTS AND UTILIZATION
Swearingen, B. / Wu, N. / Chen, S. Y. / Pulgar, S. / Biller, B. M. | 2011
PCN86 A Q-TWIST ANALYSIS COMPARING PANITUMUMAB PLUS BEST SUPPORTIVE CARE (BSC) WITH BSC ALONE IN PATIENTS WITH WILD-TYPE KRAS METASTATIC COLORECTAL CANCER
Wang, J. / Zhao, Z. / Sherrill, B. / Peeters, M. / Wiezorek, J. / Barber, B. | 2011
PCN112 COMPARISON OF CHARACTERISTICS OF COLORECTAL CANCER PATIENTS ADMITTED EMERGENTLY, URGENTLY OR ELECTIVELY IN WEST VIRGINIA HOSPITALS BETWEEN 2003-2007
Shah, N. / Halverson, J. | 2011
PMH57 ASSOCIATION BETWEEN WORK PRODUCTIVITY AND SEVERITY OF DEPRESSION AMONG FULL-TIME EMPLOYEES AS MEASURED BY THE WPAI & HPQ
Jain, G. / Roy, A. / Harikrishnan, V. / Yu, S. / Dabbous, O. H. | 2011
PMH72 ANTIDEPRESSANT PERSISTENCE AND ASSOCIATED HEALTH CARE EXPENDITURES IN CHILDREN WITH DEPRESSION
Karkare, S. / Aparasu, R. R. / Chen, H. / Rajan, S. S. | 2011
DS1 INTEGRATING DATA SOURCES TO CONDUCT COMPREHENSIVE ONCOLOGY BASED OUTCOMES RESEARCH
Albright, F. / Bollu, V. / Kuo, K. L. / Raimundo, K. / Barney, R. / Stenehjem, D. / Brixner, D. | 2011
PHP31 REVIEW OF HIGHLY SPECIALIZED MEDICAL SERVICES IN KAZKAHSTAN WITHIN AN INTRODUCTIN OF UNIFIED NATIONAL HEALTH SYSTEM
Yergaliyev, K. / Issayeva, R. / Umralin, T. | 2011
CN2 ESTIMATED EFFECTS OF THE NATIONAL BREAST AND CERVICAL CANCER EARLY DETECTION PROGRAM ON CERVICAL CANCER MORTALITY
Ekwueme, D. U. / Uzunangelov, V. / Hoerger, T. / Saraiya, M. / Miller, J. / Hall, I. / Benard, V. / Royalty, J. / Li, C. | 2011
PHP49 UTILIZATION AND COST OF THE HEALTH PLAN - EFFECTS OF SPOUSAL BEREAVEMENT
Reis Neto, J. / Arantes, A. C. | 2011
PHP26 ANALYSIS OF THE SIX PROTECTED MEDICATION CLASSES BASED ON PLAN TYPE AND LOW INCOME SUBSIDY STATUS
Blackwell, S. / Waldron, C. / Evans, M. | 2011
PHP32 ANALYSIS OF PHARMACISTS' INTERVENTIONS ON ELECTRONIC VERSUS TRADITIONAL PRESCRIPTIONS IN TWO COMMUNITY PHARMACIES
Gilligan, A. / Miller, K. / Mohney, A. / Montenegro, C. / Schwarz, J. / Warholak, T. L. | 2011
PHP36 CATASTROPHIC INJURY-RELATED ENROLLMENT AND COSTS IN A STATE MEDICAID FEE-FOR-SERVICE PROGRAM
Smith, M. J. / Zaloshnja, E. / Miller, T. R. | 2011
QA2 CROSS-WALKING CANCER-SPECIFIC INSTRUMENTS TO THE EQ-5D AND SF-6D
Teckle, P. / Peacock, S. / van der Hoek, K. / Chia, S. / Melosky, B. / Gelmon, K. | 2011
OR1 THE ASSOCIATION BETWEEN SELF-PERCEIVED COGNITIVE DIFFICULTIES AND LEVEL OF DEPRESSION AMONG EMPLOYEES WITH CURRENT DEPRESSION
Lawrence, C. / Roy, A. / Harikrishnan, V. / Yu, S. / Dabbous, O. H. | 2011
PHP57 PATTERNS OF INSURANCE COVERAGE IN THE UNITED STATES: ANALYSIS OF THE 2004-2007 MEDICAL EXPENDITURE PANEL SURVEYS (MEPS)
Berry, E. / Kelton, C. M. / Heaton, P. C. / Guo, J. J. / Fairbrother, G. / Hanseman, D. | 2011
MD3 EVALUATING THE WILLINGNESS-TO-PAY OF MEDICARE BENEFICIARIES FOR PART D PLAN ASSISTANCE
Patel, R. A. / Walberg, M. P. / Na, J. / Hsiou, D. / Panchal, V. / Woelfel, J. A. / Galal, S. M. / Carr-Lopez, S. M. / Chan, E. K. | 2011
PHP9 IMPACT OF FREE PRESCRIPTIONS IN WALES ON PRESCRIBING - A THIN DATABASE STUDY
Thompson, M. / Sedani, T. / Blak, B. T. / Hards, M. | 2011
CN3 THE VALUE OF RESEARCH FOR ERCC1 TESTING IN STAGE I NON-SMALL CELL LUNG CANCER
Roth, J. / Carlson, J. J. / Steuten, L. / Veenstra, D. | 2011
PHP79 ROLE OF HTA SYSTEMS IN REIMBURSEMENT AND MARKET ACCESS: COMPARISON OF TURKEY AND POLAND
Kirpekar, S. / Shankland, B. / Dummett, H. | 2011
DU2 PREVALENCE AND PREDICTORS OF POTENTIALLY SIGNIFICANT DRUG-DRUG INTERACTIONS IN THE ELDERLY
Dudash, K. / Negri, G. / Baccarini, S. / Rabinowitz, C. / Maio, V. | 2011
DM1 IMPACT OF A PHARMACY REFILL MANAGEMENT SYSTEM ON OUTCOMES IN END STAGE RENAL DISEASE (ESRD) PATIENTS
Rubin, J. L. / Wilson, S. M. / Golomb, J. | 2011
DU4 THE LONG TERM UTILIZATION OF STIMULANTS IN CHILDREN AND ADOLESCENTS: A MEDICAID STUDY
Sudharshan, L. / Chen, H. | 2011
PHP15 ISSUES ASSOCIATED WITH BIOLOGIC AGENTS: HEALTHCARE STAKEHOLDER SURVEY
Toscani, M. / Vogenberg, R. / Nash, D. / Peskin, S. | 2011
QA1 COST-EFFECTIVENESS OF DUTASTERIDE AS A CHEMOPREVENTION IN PROSTATE CANCER: REDUCE WITHIN-TRIAL ANALYSIS
Earnshaw, S. R. / Chirila, C. / McDade, C. / Black, L. / Andriole, G. L. | 2011
PHP33 IMPACT OF PHARMACY AND MEDICAL PLAN INTEGRATION ON OVERALL MEDICAL COSTS
Bunz, T. J. / Nguyen, H. V. / Regine, M. L. | 2011
PMD17 ANALYSIS OF COST DRIVERS IN STRUCTURED SMBG IN POORLY CONTROLLED, NON-INSULIN TREATED TYPE-2 DIABETES: RESULTS FROM THE STEP STUDY
Myers, J. / Berndt, K. / Wegmann, N. / Rees, C. / Mast, O. / Wagner, R. | 2011
PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO
Chen, W. / Ellis, P. / Levin, L. / Krahn, M. | 2011
PDB46 DEVELOPMENT OF THE DIABETIC PERIPHERAL NEUROPATHIC PAIN IMPACT MEASURE: A PATIENT-REPORTED OUTCOME MEASURE OF THE IMPACT OF DPNP ON FUNCTIONING
Brod, M. / Carson, R. / Ramasamy, A. / Setyawan, J. | 2011
PDB56 IMPACT OF PHARMACIST MANAGEMENT ON PATIENTS WITH DIABETES ENROLLED IN A RURAL FREE CLINIC
Franklin, M. / Sease, J. M. / Gerrald, K. R. | 2011
PDB17 ASSOCIATION OF YOUNGER AGE WITH POOR GLYCAEMIC AND CHOLESTEROL CONTROL IN ASIANS WITH TYPE-2 DIABETES IN SINGAPORE
Toh, M. P. / Wu, C. X. / Heng, B. H. | 2011
PDB54 USE OF ELECTRONIC MEDICAL RECORDS FOR CLINICAL RESEARCH IN THE MANAGEMENT OF TYPE-2 DIABETES
Kamal, K. M. / Civitarese, L. | 2011
PMS3 RISK FACTORS FOR NON-INITIATION OF DISEASE MODIFYING ANTI-RHEUMATIC DRUGS (DMARD) BY PATIENTS WITH NEWLY DIAGNOSED RHEUMATOID ARTHRITIS (RA)
Bonafede, M. / Johnson, B. H. / Fox, K. M. / Watson, C. / Gandra, S. R. | 2011
PRS44 THE CHARIOT STUDY: NOVEL DATA COLLECTION, VIEWING AND DYNAMIC REPORTING MECHANISM
Arnold, R. J. / Groesser, K. / Baldwin, R. | 2011
PCV107 IDENTIFYING EFFICIENT ACUTE CLINICAL PATHWAYS FOR CHEST PAIN: USING RISK ADJUSTED COST-EFFECTIVENESS (RAC-E) TO COMPARE HOSPITALS USING LINKED, ROUTINELY COLLECTED DATA
Caffrey, O. / Pham, C. / Karnon, J. / Ben-Tovim, D. I. / Hakendorf, P. / Crotty, M. | 2011
PSY45 CHARACTERISTICS OF CAREGIVERS AND THEIR EXPERIENCE ASSOCIATED WITH CONGENITAL HEMOPHILIA OF INHIBITOR PATIENTS
Wisniewski, T. / Petrilla, A. A. / DeKoeven, M. / Lee, W. C. / Cooper, D. L. / Holot, N. / von Mackensen, S. | 2011
PSY81 PERCEPTIONS ABOUT 'RAPID' WARFARIN REVERSAL WITH FRESH FROZEN PLASMA TO REDUCE THE INR: A NOVEL SURVEY METHODOLOGY
Petrozzino, J. / Hoesche, J. / Jones, C. | 2011
PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE
Vegter, S. / Tolley, K. / Levin, A. / Lok, C. E. / Morton, A. R. / Soroka, S. D. / Keith, M. S. / Postma, M. J. | 2011
PMS23 COST-EFFECTIVENESS ANALYSIS OF ANALGESIC THERAPY FOR POSTOPERATIVE PAIN AFTER TOTAL HIP ARTHROPLASTY IN MEXICO
Contreras, I. / Mould-Quevedo, J. F. / Goycochea-Robles, M. V. / Torres-Gonzalez, R. / Gardu&#x00F1 / o-Espinosa, J. | 2011
PMS53 USE OF TNF-INHIBITORS IN THE UNITED STATES: UTILIZATION PATTERNS AND DOSE-ESCALATION FROM A REPRESENTATIVE UNITED STATES RA POPULATION
Bedenbaugh, A. / Cyhaniuk, A. / Khanna, D. | 2011
PMS38 IMPACT OF MEDICARE PART D COVERAGE GAP ON MEDICATION TAKING BEHAVIOR: AN EVALUATION ACROSS DUAL AND NON-DUAL ELIGIBLE BENEFICIARIES DIAGNOSED WITH RHEUMATOID ARTHRITIS
Shahpurwala, Z. S. / Datar, M. / Banahan, B. F. | 2011
PMD13 POST INGUINAL HERNIA REPAIR PAIN MANAGEMENT COSTS: A STUDY USING THE PREMIER PERSPECTIVE ™ DATABASE (PPD)
Morseon, M. / Hashemi, L. | 2011
PRS4 LITERATURE REVIEW OF RISK FACTORS FOR MORTALITY OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Cheng, Y. / Raisch, D. W. / Roberts, M. | 2011
PMD34 PREFERENCES FOR GENETIC TESTING TO ASSESS COLON-CANCER RISKS
Mohamed, A. F. / Johnson, F. R. / Knight, S. J. | 2011
PRM30 RESULTS FROM A NEW VISUAL ANALOGUE SCALE PROTOCOL FOR EQ-5D VALUATIONS
Bailey, H. / La Foucade, A. / Kind, P. | 2011
PDB61 DECOMPOSING GENDER DIFFERENCES IN ANGIOTENSIN II CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS AMONG VETERANS WITH DIABETES
Sambamoorthi, U. / Tiwari, A. / Maney, M. / Pogach, L. | 2011
PCV62 PERSISTENCE AND COMPLIANCE IN HYPERTENSION TREATMENT WITH OLMESARTAN MEDOXOMIL – ANALYSIS OF REAL-LIFE PRESCRIPTION DATA
Sandberg, A. / Kostev, K. / Ehlken, B. / Holz, B. / Oberdiek, A. | 2011
PIN41 INFLUENZA VACCINATION RATES AMONG HIGH RISK GROUPS IN THE UNITED STATES
DiBonaventura, M. / Wagner, J. S. / Goren, A. | 2011
PCN69 AN ECONOMIC EVALUATION OF DASATINIB FOR THE TREATMENT OF IMATINIB RESISTANT PATIENTS WITH ADVANCED PHASE CHRONIC MYELOGENOUS LEUKAEMIA
Taylor, M. / Lewis, L. / Lebmeier, M. / Wang, Q. | 2011
PCN22 ASSESSMENT OF SAFETY PROFILE OF TRASTUZUMAB IN METASTATIC BREAST CANCER PATIENTS
Rana, C. / Mann, K. / Wadhwa, A. | 2011
PCN19 AN EPIDEMIOLOGICAL MODEL OF BREAST CANCER AND PROGRESSION TO BONE METASTASES IN THE UNITED KINGDOM
Martin, M. / Kearney, M. / Bracco, A. / Brown, J. | 2011
PIH11 COST ANALYSIS OF TOTAL PARENTERAL NUTRITION IN THE NEONATAL AND PEDIATRIC CARE IN BELGIAN HOSPITALS
Walter, E. / Maton, P. / Dragosits, A. / Sondhi, S. / Turpin, R. / Liu, F. X. | 2011
PCN43 STUDY ON MEDICAL EXPENDITURE AND PAYMENT PATTERNS OF INSURED PATIENTS WITH CANCER IN CHINA
Xiong, X. / Lin, J. / Chen, W. | 2011
PCN90 PRO INSTRUMENTS USED TO MEASURE SYMPTOM IMPACTS OF FATIGUE AND PAIN IN PROSTATE CANCER DRUGS TRIALS
Peeters, P. / Casamayor, M. / Mo&#x00EF / se, P. / Holmstrom, S. | 2011
PCN97 IMPACT OF GLOBAL HEALTH CARE REFORMS ON PRICING, ACCESS AND HEALTH ECONOMICS AND OUTCOMES STRATEGY
Aggarwal, S. | 2011
PCN100 RACIAL DISPARITIES IN AFRICAN AMERICAN VERSUS WHITE WOMEN WITH NEWLY DIAGNOSED BREAST CANCER IN A SOUTHEAST UNITED STATES HEALTH PLAN
Fisher, M. / Cai, Q. / Paoli, C. J. / Lyons, A. / Wasser, T. / Rodriguez, N. / White, S. / Kallich, J. / Barron, J. / Brawley, O. W. | 2011
PCN113 LEARNING THE LESSONS OF ONCOLOGY HTA REVIEWS IN AUSTRALIA & THE UNITED KINGDOM – A CASE STUDY OF FIVE DRUGS
Lewis, S. / Dummett, H. | 2011
PCN105 ESTIMATING NICE'S COST EFFECTIVE THRESHOLD FOR END-OF-LIFE CANCER TREATMENTS
Mo&#x00EF / se, P. / Fassler, P. | 2011
PCN130 RECORD-LINKAGE FOR PHARMACOEPIDEMIOLOGIC STUDIES IN CANCER PATIENTS
van Herk-Sukel, M. P. / Lemmens, V. / van de Poll, L. / Herings, R. M. / Coebergh, J. W. | 2011
PCN118 PREDICTING THE FUTURE IMPACT OF EMERGING TECHNOLOGIES ON HEPATOCELLULAR CARCINOMA (HCC): MEASURING STAKEHOLDERS PREFERENCES WITH BEST-WORST SCALING
Gallego, G. / Bridges, J. F. / Flynn, T. / Blauvelt, B. M. | 2011
PMH23 COMPARISON OF HEALTH CARE COSTS AND UTILIZATIONS BETWEEN PATIENTS WHO WERE TREATED WITH AND WITHOUT MEDICATION FOR OPIOID DEPENDENCY
Baser, O. / Wang, L. / Xie, L. | 2011
PIN13 IMPACT OF NEWLY DIAGNOSED HEPATITIS C INFECTIONS ON HEALTH CARE COSTS
McCombs, J. / Shin, J. / Saab, S. / Hines, P. / Yuan, Y. | 2011
PCV29 IMPROVING BLEEDING RISK ASSESSMENT FOR ANTICOAGULANT USE IN ATRIAL FIBRILLATION
Lee, E. H. / Kwong, W. J. / Casciano, J. / Martin, B. | 2011
PCV40 COST AND PRACTICE OF TREATMENT OF ACUTE ISCHEMIC STROKE IN REAL WORLD SETTINGS IN RUSSIA
Vorobyev, P. / Bezmelnitsyna, L. / Borisenko, O. | 2011
PMH63 RISK-BENEFIT ANALYSIS OF DEPRESSION TREATMENT FOR CHILDREN AND YOUNG ADULTS
Soeteman, D. I. / Miller, M. / Kim, J. | 2011
PMH27 IDENTIFICATION AND COST OF TREATMENT-RESISTANT DEPRESSION USING A CLAIMS SIGNATURE
Bates, J. A. / Cooke, C. E. / Hahn, N. M. / Lee, H. Y. / Forbes, R. A. / Jing, Y. | 2011
PMS27 A COST-EFFECTIVENESS ANALYSIS FROM AN INSTITUTIONAL PERSPECTIVE TO COMPARE ZOLEDRONIC ACID WITH STANDARD OF CARE IN THE PREVENTION OF HIP FRACTURES IN PATIENTS WITH OSTEOPOROSIS
Briones, B. / Bravo, M. G. / Garc&#x00ED / a-Contreras, F. | 2011
PRS36 HOSPITALIZATIONS, MEDICAL MANAGEMENT AND SWITCH THERAPY PATTERNS IN THE COPD MEDICARE POPULATION
Ejzykowicz, F. / Hay, J. / Sarocco, P. / Karafilidis, J. / Walsh, J. | 2011
PDB7 DIET THERAPIES IN PATIENTS WITH TYPE-2 DIABETES: A MIXED-TREATMENT COMPARISON OF RANDOMIZED CONTROL TRIALS
Harrington, A. R. / Malone, D. | 2011
PRM33 TAKE TIME TO TRAIN: EVIDENCE TO SHOW THAT PATIENT TRAINING IN ELECTRONIC PATIENT REPORTED OUTCOMES IS BENEFICIAL
Ross, J. / Ross, E. / O'Gorman, H. J. / Peck, R. | 2011
PCN3 CARDIOVASCULAR COMORBIDITIES AMONG PATIENTS WITH METASTATIC COLORECTAL CANCER
Overbeek, J. A. / Zhao, Z. / van Herk-Sukel, M. P. / Barber, B. L. / Gao, S. / Herings, R. M. | 2011
PDB59 THE COMPLEXITY OF DRUG THERAPY AND SOCIO-ECONOMIC VARIANTS IN PATIENTS WITH DIABETES
Zhang, J. / Tao, J. | 2011
PCN52 WILLINGNESS TO PAY AND COST BENEFIT ANALYSIS OF DELIVERY METHODS FOR DECISION SUPPORT FOR RURAL CANCER PATIENTS
Wilson, L. S. / Loucks, A. / Franklin, L. / O'Donnell, S. / Moore, D. / Jupiter, C. / Kong, S. / Yeung, R. / Belkora, J. | 2011
PCN57 ECONOMICS OF A MULTI-GENE ASSAY TO PREDICT RECURRENCE OF EARLY STAGE BREAST CANCER: EXPERIENCE OF A LARGE UNITED STATES INSURANCE PROGRAM
Hornberger, J. / Chien, R. / Kreb, K. / Hochheiser, L. I. | 2011
PCN60 COST-EFFECTIVENESS OF PEGFILGRASTIM VERSUS FILGRASTIM AFTER HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMA AND MYELOMA
Perrier, L. / Lefranc, A. / Quittet, P. / Moreau, P. / Siani, C. / Ghesqui&#x00E8 / res, H. / Jardin, F. / Favier, B. / Ifrah, N. et al. | 2011
PGI22 CONCORDANCE AMONG MULTIPLE HEALTH OUTCOMES MEASURES IN RESPONSIVENESS TO MULTI-MATRIX MESALAMINE MAINTENANCE TREATMENT FOR PATIENTS WITH QUIESCENT ULCERATIVE COLITIS
Yen, L. / Yarlas, A. / Hodgkins, P. | 2011
PMH39 COST-EFFECTIVENESS OF ANTIDEPRESSANT THERAPIES IN KOREA
Shin, S. / Jung, S. Y. / Song, H. / Park, J. / Ahn, J. | 2011
PND4 DIAGNOSIS OF SHIFT WORK DISORDER AND THE IMPACT OF EXCESSIVE SLEEPINESS: RESULTS FROM SHIFT WORKERS, PATIENTS WITH SHIFT WORK DISORDER, AND HEALTH CARE PROFESSIONALS PARTICIPATING IN AN INTERNET SURVEY
Anderson, C. / Sylvester, L. / Paik, S. | 2011
PND20 HEALTHCARE UTILIZATION AND COSTS AMONG AD PATIENTS WITH AND WITHOUT DYSPHAGIA
Gabriel, S. / Tian, H. / Kim, E. / Kahler, K. H. | 2011
PMH56 COMPARISON OF DIFFERENT COMORBIDITY MEASURES FOR PREDICTING PHYSICAL AND MENTAL HEALTH IN DEMENTIA
Chitnis, A. / Bhowmik, D. / Dwibedi, N. / Mehta, S. / Kamble, P. / Johnson, M. L. | 2011
PMH30 INDIRECT COSTS (IC) OF ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 FROM THE MEDICAL EXPENDITURES PANEL SURVEY (MEPS)
Kavati, A. / Rappaport, H. | 2011
PCV48 COST-EFFECTIVENESS ANALYSIS OF ANTIARRHYTHMIC THERAPIES FOR THE TREATMENT OF SUPRAVENTRICULAR TACHYCARDIA AND SURGICALLY INDUCED TACHYCARDIAS AND HYPERTENSION
Dexter, F. / Yang, J. / Carlton, R. / Bramley, T. / Harb, G. | 2011
PHP91 ASSOCIATION BETWEEN QUALITY OF CARE AND SHORT TERM OUTCOMES FOR VERY OLD PATIENTS HOSPITALIZED FOR ACUTE ILLNESSES
Chong, W. F. / Ding, Y. Y. / Sun, Y. / Heng, B. H. | 2011
PDB10 ASSESSING THE ABILITY OF PATIENT REPORTED MEASURES TO DISCRIMINATE PROXIES FOR TREATMENT RESPONSE
Cantrell, R. / Brenneman, S. / Kaplan, S. / Shen, W. / Brekke, L. / Billimek, J. / Paczkowski, R. / Haynes, V. / Greenfield, S. / Buesching, D. | 2011
PRS2 INCREASED PREVALENCE OF OBSTRUCTIVE LUNG DISEASE IN PATIENTS WITH OBSTRUCTIVE SLEEP APNEA
Greenberg-Dotan, S. / Reuveni, H. / Tal, A. / Oksenberg, A. / Cohen, A. / Shaya, F. T. / Tarasiuk, A. / Scharf, S. M. | 2011
PRS3 RELATIVE EFFECTIVENESS STUDY OF OMALIZUMAB: THE USE OF BEFORE-AFTER COHORT METHODOLOGY FOR COVERAGE WITH EVIDENCE DEVELOPMENT
Grimaldi-Bensouda, L. / Zureik, M. / Molimard, M. / Aubier, M. / Abenhaim, L. | 2011
PCV106 RE-HOSPITALIZATION RATES OF ACUTE CORONARY SYNDROME PATIENTS IN REAL WORLD CLINICAL PRACTICE: OBSERVATIONS FROM A NATIONAL ADMINISTRATIVE CLAIMS DATA
Tunceli, O. / Gandhi, S. K. / Bhandary, D. / Stephenson, J. J. / Gold, A. / Fu, A. C. / Kern, D. M. / Singer, J. | 2011
PSY10 COST ANALYSIS OF ANEMIA TREATMENT WITH ERYTHROPOIESES-STIMULATING AGENTS (ESAS) IN CANCER PATIENTS RECEIVING CHEMOTHERAPY: A MULTICOUNTRY APPROACH
Duran, A. / Spaepen, E. / Lamotte, M. / Walter, E. / Lucioni, C. / Pinheiro, B. / Brosa, M. / Kutikova, L. / Pujol, B. / Annemans, L. | 2011
PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW
Chan, E. K. / Darmawanti, I. / Mulyana, O. P. / Zumbo, B. D. | 2011
PSY27 REAL-WORLD EVALUATION OF HEALTH CARE RESOURCE UTILIZATION AND COSTS IN PATIENTS WITH NEUROPATHIC PAIN ASSOCIATED WITH DIABETIC PERIPHERAL NEUROPATHY (PDPN) TREATED WITH PREGABALIN OR GABAPENTIN
Udall, M. / Mardekian, J. / Harnett, J. | 2011
PSY38 PATIENT-REPORTED OUTCOMES IN SUBJECTS WITH PAINFUL DIABETIC PERIPHERAL NEUROPATHY: PAIN DESCRIPTION AND QUALITY OF LIFE
Ko, K. S. / Cha, B. Y. / Kim, C. H. / Kwon, H. S. / Lee, J. H. / Park, T. S. / Won, J. C. / Ko, S. K. / Park, H. J. | 2011
PMS15 COMPARING HEALTH-RISK BURDEN, LOST PRODUCTIVITY, AND TOTAL HEALTH CARE COSTS AMONG INDIVIDUALS WITH RHEUMATOID ARTHRITIS AND TOP FIVE CHRONIC DISEASES
Naim, A. / Pitts, J. / Chen, C. Y. / Wright, D. / Edington, D. | 2011
PMD6 READMISSION RATES AND COSTS ASSOCIATED WITH FIBRIN SEALANT USE AMONG PATIENTS UNDERGOING ORTHOPEDIC SURGERY
Ye, X. / Shah, M. / Rupnow, M. F. / Hammond, J. | 2011
PSU10 COST-EFFECTIVENESS OF PRIMARY PCI WITHOUT ONSITE SURGICAL BACKUP
Ramos, P. | 2011
PHP113 IQWIG AND HIQA, WHAT ARE THEY GOOD FOR? THE EVOLUTION OF THE HTA AGENCY: TIME FROM CREATION TO FIRST ASSESSMENT AND IMPACTFUL APPRAISAL
Green, M. J. | 2011
PIN3 A META-ANALYSIS OF EFFICACY AND SAFETY OF LINEZOLID FOR INFECTED DIABETIC FOOT TREATMENT
Villasis-Keever, M. A. / Rendon-Macias, M. / Esacamilla-Nu&#x00F1 / ez, A. / Mould-Quevedo, J. / Muci&#x00F1 / o-Ortega, E. / Galindo-Suarez, R. M. | 2011
PIN9 BUDGET IMPACT MODEL OF ABACAVIR/LAMIVUDINE FOR TREATMENT OF HIV INFECTED PATIENTS IN MEXICO
Rely, K. / Salinas Escudero, G. / Alexandre, P. K. | 2011
PCN59 COST EFFECTIVENESS ANALYSIS OF LAPATINIB/CAPECITABINE (LC) VERSUS TRASTUZUMAB/CAPECITABINE (TC) IN PATIENTS WITH METASTATIC BREAST CANCER ERBB2+ AFTER PROGRESSION TO THE FIRST SCHEME OF TRASTUZUMAB
Anaya, P. / Aldaco, F. | 2011
PCN27 COMPARATIVE BUDGET IMPACT OF FORMULARY INCLUSION OF ZOLEDRONIC ACID AND DENOSUMAB FOR PREVENTION OF SKELETAL-RELATED EVENTS IN PATIENTS WITH BONE METASTASES
Bell, M. J. / Miller, J. D. / Namjoshi, M. / Russell, M. W. | 2011
PIN47 CRITICAL SUCCESS FACTORS FOR THE UPTAKE OF NOVEL VACCINES ONTO NATIONAL IMMUNUSATION PROGRAMMES
Oshinowo, B. / Grosvenor, A. / Ng-Haing, J. | 2011
PIH17 COST-EFFECTIVENESS OF ABLE A FUNCTIONAL PROGRAM TO DECREASE MORTALITY IN COMMUNITY-DWELLING OLDER ADULTS
Jutkowitz, E. / Gitlin, L. / Pizzi, L. T. / Lee, E. H. / Dennis, M. | 2011
PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY
Paulden, M. / Franek, J. / Pham, B. / Krahn, M. | 2011
PMD26 ECONOMIC EVALUATIONS FOR SCREENING AND TREATMENTS OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA: A SYSTEMATIC REVIEW
Lin, V. / Yeh, W. S. / Kowalski, J. | 2011
PMD30 IMPACT OF ACCESS TO A USUAL SOURCE OF CARE ON COMPLIANCE TO BREAST AND CERVICAL CANCER SCREENING
Datar, M. V. / Wu, W. K. | 2011
PSU11 REDUCTION IN HEALTHCARE UTILIZATION AND EXPENDITURES IN PATIENTS TREATED WITH CATHETER ABLATION FOR ATRIAL FIBRILLATION (AF) IN THE UNITED STATES
Ladapo, J. A. / David, G. / Gunnarsson, C. / Hao, S. / White, S. / March, J. / Zang, M. / Reynolds, M. | 2011
PDB41 TREATMENT GAPS AMONG GROWTH HORMONE USERS IN A NATIONAL MANAGED CARE POPULATION IN THE UNITED STATES
Fincher, C. / Kozma, C. / Meletiche, D. M. / Velez, F. | 2011
PSU19 NATIONWIDE UTILIZATION PATTERN OF WHOLE BRAIN RADIOTHERAPY AND STEREOTACTIC RADIOSURGERY FOR BRAIN METASTASIS
Jung, S. Y. / Hwang, J. S. / Choi, J. E. / Shin, S. Y. / Kim, J. H. / Hyun, M. K. / Kim, Y. E. / Bae, J. M. | 2011
PHP88 INFLUENCE OF HOSPITAL CHOICES OF DRUGS ON THE PHARMACEUTICAL CONSUMPTION IN THE COMMUNITY
Gallini, A. / Legal, R. / Taboulet, F. | 2011
PCV6 ANALYSIS OF MYOCARDIAL INFARCTION RELATED CLINICAL OUTCOMES, HEALTH CARE UTILIZATION AND COSTS OF PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION
Wang, L. / Xie, L. / Baser, O. | 2011
PCV11 PNEUMONIA AFTER ACUTE ISCHEMIC STROKE: PREVALENCE, ASSOCIATED FACTORS AND OUTCOMES
Al-Jabi, S. W. / Hassan, Y. / Abd Aziz, N. / Looi, I. / Zyoud, S. H. | 2011
PIH39 THE EFFECT OF ELECTRONIC-MEDICAL-RECORD SYSTEM SOPHISTICATION ON PREVENTIVE HEALTH CARE FOR WOMEN
Tundia, N. / Heaton, P. / Cavanaugh, T. / Guo, J. J. / Hanseman, D. / Kelton, C. M. | 2011
PIN8 EPIDEMIOLOGY OF METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS AT A MIDWESTERN ACADEMIC HEALTH CARE CENTER
Joshi, M. V. / Iwen, P. / Simonsen, K. / Tibbits, M. / Islam, M. | 2011
PIN21 COST EFFECTIVENESS ANALYSIS OF VACCINATION PROGRAMS WITH 10-VALENT (PCV10) AND 13-VALENT (PCV13) PNEUMOCOCCAL VACCINES IN COLOMBIA
Coronel, W. / Jaramillo, J. / Caceres, H. A. / Riveros, L. | 2011
PMH37 THE COST-EFFECTIVENESS OF GUANFACINE EXTENDED RELEASE (GXR) VERSUS ATOMOXETINE (ATX) FOR THE TREATMENT OF ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD) IN CHILDREN AND ADOLESCENTS
Erder, M. / Chen, K. / Wu, E. Q. / Hodgkins, P. / Sikirica, V. | 2011
PMH6 DIFFERENTIAL RATES OF SIDE EFFECTS IN DEPRESSED ADULTS AND ADOLESCENTS BEING TREATED WITH ANTIDEPRESSANTS
Anderson, H. D. / Libby, A. M. / Pace, W. D. / West, D. R. / Valuck, R. J. | 2011
PCV76 PATIENT SYMPTOM EXPERIENCES FOLLOWING A MYOCARDIAL INFARCTION
Gwaltney, C. / Martin, M. L. / Falvey, H. | 2011
PCV88 PATTERNS OF STATIN PRESCRIPTION AMONG PRIVATELY INSURED COMMERCIAL AND MEDICARE PATIENTS
Bae, J. P. / Peng, X. / Zhao, Z. / Zagar, A. / Sponseller, C. A. / LeNarz, L. A. | 2011
PSY74 TREATMENT CHOICE FOR PAIN MANAGEMENT IN NURSING HOME HOSPICE/PALLIATIVE CARE RESIDENTS IN THE UNITED STATES
Agrawal, R. / Mhatre, S. K. / Sansgiry, S. | 2011
PMD2 A META-ANALYSIS OF BIOMARKERS AND DIAGNOSTIC IMAGING IN ALZHEIMER'S DISEASE
Sullivan, S. D. / Bloudek, L. / Spackman, D. E. / Blankenburg, M. | 2011
PCN133 ESTIMATING THE EPIDEMIOLOGY OF LATE-STAGE CANCERS – A MATHEMATICAL APPROACH
Pan, F. / Sorensen, S. / Stern, S. | 2011
PGI11 THE ECONOMIC AND QUALITY OF LIFE BURDEN OF ILLNESS IN CHRONIC CONSTIPATION (CC) AND IRRITABLE BOWEL SYNDROME (IBS): A SYSTEMATIC REVIEW
Yee, K. / Nellesen, D. / Chawla, A. / Carson, R. / Lewis, B. | 2011
PMH38 ECONOMIC IMPLICATIONS OF THE EFFECT OF LURASIDONE VERSUS OTHER SELECTED ATYPICAL ANTIPSYCHOTICS ON CARDIOMETABOLIC PARAMETERS IN PATIENTS WITH SCHIZOPHRENIA
Guo, S. / Hernandez, L. / Green, J. / Sarocco, P. | 2011
PND15 THE INCREMENTAL COST OF ALZHEIMER'S DISEASE IN THE CALIFORNIA MEDICAID PROGRAM (MEDI-CAL)
McCombs, J. / Chu, K. / Mucha, L. | 2011
PND41 PARNETING STRESS IN CARING FOR CHILDREN DIAGNOSED WITH NEURO-DEVELOPMENTAL DISORDER
Almogbel, Y. S. / Goyal, R. / Sansgiry, S. | 2011
PND39 MULTIPLE SCLEROSIS PATIENTS REPORT IMPROVEMENTS IN FATIGUE AND COGNITIVE FUNCTIONING AFTER ONE YEAR OF NATALIZUMAB TREATMENT
Stephenson, J. J. / Agarwal, S. S. / Kern, D. M. / Kamat, S. A. | 2011
PSU21 THE REUSE OF SINGLE-USE SURGICAL DEVICES: EVALUATION OF THE ECONOMIC EVIDENCE
Emmermann, A. / Schroeer, P. / Hamerslag, L. / Kusel, J. | 2011
PSU25 IDENTIFYING IMPROVEMENT OF PRESSURE ULCER PREVENTION AT THE POINT-OF-CARE WITH MULTIPLE METHODS IN THE DEPARTMENT OF SURGERY
Padula, W. V. / Mishra, M. K. / Weaver, C. D. / Yilmaz, T. / Splaine, M. E. | 2011
PMH66 MULTIMORBIDITY AND DEPRESSION TREATMENT
Vyas, A. / Sambamoorthi, U. | 2011
PHP98 A TREND ANALYSIS OF NEW MOLECULAR ENTITIES WITHDRAWN FOR SAFETY REASONS FROM 1980 TO 2009 IN THE UNITED STATES
Seoane-Vazquez, E. / Rodriguez-Monguio, R. / Qureshi, Z. P. / Szeinbach, S. L. | 2011
PCV53 COST-EFFECTIVENESS ANALYSIS COMPARING IVABRADINE WITH ISOSORBIDE MONONITRATE, AMLODIPINE, DILTIAZEM AND VERAPAMIL, IN THE TREATMENT OF STABLE ANGINA PECTORIS
Ergene, O. / Erol, M. K. / Oto, A. / Kucukoglu, S. / Ozdemir, O. / Tan, M. | 2011
PMS32 ECONOMIC EVALUATION OF THE TREATMENT OF RHEUMATOID ARTHRITIS WITH ANTI-TNF BIOLOGICAL THERAPIES IN COLOMBIA
Quintana, G. / Restrepo, J. P. / Caceres, H. A. / Rueda, J. D. / Rosselli, D. | 2011
PIN48 TRENDS IN FUNDING OF SPECIALIST VACCINES
Scott, S. A. / Forster, L. | 2011
PMS9 COST CONSEQUENCE OF COLCHICINE APPROVAL IN THE MEDICAID PROGRAMS IN THE UNITED STATES
Zhang, Y. J. / Kelton, C. / Guo, J. J. | 2011
PCV78 HEALTH RELATED QUALITY OF LIFE IN HYPERTENSIVE PATIENTS VISITING PUBLIC HOSPITALS OF QUETTA, PAKISTAN
Saleem, F. / Hassali, M. A. / Shafie, A. A. / Bashir, S. | 2011
PCV61 THE IMPACT OF THE MEDICARE DOUGHNUT HOLE ON MEDICATION USE BEHAVIORS AND HEALTH CARE RESOURCE UTILIZATION AMONG BENEFICIARIES TAKING STATIN MEDICATION
Joshi, N. / Banahan, B. F. | 2011
PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS
Hiligsmann, M. / Salas, M. / Hughes, D. A. / Manias, E. / Gwadry-Sridhar, F. / Linck, P. / Cowell, W. | 2011
PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITY
Mitsakakis, N. / Wijeysundera, H. C. / Krahn, M. | 2011
PSS11 COST-EFFECTIVENESS ANALYSIS OF FORMULARY MANAGEMENT STRATEGIES FOR FIRST-LINE AGENTS USED IN OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION
Blaser, D. A. / Ousterhout, M. M. / Gagnon, J. M. / Calabrese, D. | 2011
PSY13 THE COST OF OBESITY AND ITS MAJOR COMORBIDITIES: ANALYSIS FROM A COMMERCIAL CLAIMS DATABASE
Padula, W. V. / Nair, K. V. | 2011
PSY32 HOW DO MINIMALLY IMPORTANT DIFFERENCES VALUE OUTCOMES?
Suh, J. K. / Doctor, J. | 2011
PRM12 DOES DIFFERENTIAL DISCOUNTING ENHANCE DECISION MAKING?
O'Mahony, J. / van Rosmalen, J. | 2011
PCN14 UNMET NEED IN METASTATIC PROSTATE CANCER PATIENTS: RESULTS FROM A SYSTEMATIC REVIEW
Wu, Y. / Modha, R. / Sehgal, M. / Dhawan, R. | 2011
PUK9 MEDICAL CARE SPENDING ASSOCIATED WITH CHRONIC KIDNEY DISEASE BY STAGE OF DISEASE: A POPULATION-BASED STUDY
Taylor, T. N. / Salinitri, F. D. / Satterthwaite, D. W. | 2011
PSY77 COMPARISON OF OBESITY-ASSOCIATED COMORBIDITIES BETWEEN EMR AND CLAIMS DATABASES
Brixner, D. / Bron, M. / Bellows, B. K. / Ye, X. / Harikrishnan, V. / Oderda, G. | 2011
PUK12 COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS
Arreola-Ornelas, H. / Rosado-Buzzo, A. / Garcia-Mollinedo, M. / Camacho-Cordero, L. / Muci&#x00F1 / o-Ortega, E. / Mould-Quevedo, J. F. / Galindo-Suarez, R. M. | 2011
PMS8 THE BUDGET IMPACT OF LOWER GPA ADHERENCE IN PATIENTS WITH CHRONIC NON-STEROIDAL AND COX-2 INHIBITOR USE
Bonafede, M. / Johnson, B. H. / Crawley, J. / Hellmund, R. | 2011
PMS67 FREQUENCY OF SELECT ANTI-TNF ADMINISTRATION OR RE-FILL IN PATIENTS WITH RHEUMATOID ARTHRITIS
Schmeichel-Mueller, C. / Bartels, A. / Silver, J. / Bolge, S. / Ingham, M. | 2011
PMD9 ESTIMATION OF QUALITY-ADJUSTED LIFE EXPECTANCY AND LOSS OF QUALITY-ADJUSTED LIFE EXPECTANCY IN PATIENTS UNDER PROLONGED MECHANICAL VENTILATION: A POPULATION-BASED STUDY DURING 1998-2007 IN TAIWAN
Hung, M. C. / Wang, J. D. | 2011
PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY
Duh, M. S. / Faught, E. / Guerin, A. / Sarda, S. P. / Samuelson, T. / Bunker, M. T. / Olin, B. D. / Jackson, S. D. / Helmers, S. L. | 2011
PSU16 LAPAROSCOPIC SUPRACERVICAL HYSTERECTOMY VERSUS LAPAROSCOPIC-ASSISTED VAGINAL HYSTERECTOMY: POST-SURGICAL OUTCOMES AND COSTS
Waters, H. / Song, X. / Pan, K. / Subramanian, D. / Sedgley, R. / Raff, G. J. | 2011
PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALES
Maunsell, E. / Lauzier, S. / Brunet, J. / Campbell, S. / Elsworth, G. / Osborne, R. H. | 2011
PMH71 HEALTH CARE RESOURCE UTILIZATION (HRU) AND DIRECT MEDICAL EXPENDITURES (DME) FOR ADULT WOMEN WITH ANXIETY DISORDERS (AD) IN THE UNITED STATES IN 2006 USING MEDICAL EXPENDITURES PANEL SURVEY (MEPS)
Kavati, A. / Rappaport, H. | 2011
PMH41 ECONOMIC EVALUATION OF DESVENLAFAXINE IN THE ACUTE MANAGEMENT OF INPATIENTS WITH MAJOR DEPRESSIVE DISORDER FROM A BRAZILIAN PUBLIC HOSPITAL PERSPECTIVE
Scaccabarozzi, L. / Takemoto, M. L. / Fernandes, R. A. / Santos, P. M. / Tolentino, A. C. | 2011
PND9 FACTORS AFFECTING FUNCTIONAL DEPENDENCE IN ALZHEIMER PATIENTS RESIDING IN NURSING HOMES IN THE UNITED STATES - USING NATIONAL NURSING HOME SURVEY (NNHS-2004)
Kale, H. / Nair, R. | 2011
MD4 EVALUATION OF AN INTERVENTION TO REDUCE POLY-PHARMACY IN MEDICARE PART D
Livengood, K. B. / Harrell, T. / Abarca, J. | 2011
PHP7 DEVELOPING PUBLIC HEALTH GUIDANCE - WHAT ARE THE DATA GAPS? REVIEW OF THE GAPS IN THE EVIDENCE IDENTIFIED BY NICE IN THE UNITED KINGDOM
Kusel, J. / Costello, S. / Hamer, N. / Roper, S. / Hamerslag, L. | 2011
PHP46 THE STATE OF HEALTH ECONOMIC EVALUATION IN SOUTH AFRICA: A SYSTEMATIC REVIEW
Gavaza, P. / Rascati, K. L. / Oladapo, A. O. / Khoza, S. | 2011
SB1 COMPARISON OF DIFFERENCE-IN-DIFFERENCE, PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLES IN ESTIMATING COST DIFFERENCES BETWEEN TWO COHORTS
Cao, Z. / Song, X. | 2011
EV3 A COMPARATIVE EFFECTIVENESS INDEX TO INFORM CLINICAL DECISIONS
Horowicz-Mehler, N. / Doyle, J. / Arikian, S. / Hagan, M. | 2011
Copyright/Subscription
| 2011
PHP86 IRRATIONAL USE OF ANTIBIOTICS AND ROLE OF PHARMACISTS: AN INSIGHT FROM A QUALITATIVE STUDY IN NEW DELHI, INDIA
Kotwani, A. / Wattal, C. / Joshi, P. C. / Holloway, K. | 2011
PHP25 THE POTENTIAL VALUE OF THE 2014 MEDICAID EXPANSION
Sepulveda, B. / Doyle, J. | 2011
PHP66 DEMONSTRATING “DISEASE MODIFYING THERAPIES”? AN HTA PERSPECTIVE
McDonald, P. / Colasante, W. / Oshinowo, B. / Saraf, S. | 2011
PHP11 REVIEW OF ADJUSTMENT OF ESSENTIAL MEDICINE LIST AT PROVINCIAL LEVEL IN CHINA
Shi, L. W. / Ma, Y. Q. / Xu, L. P. / Zhao, D. H. / Zhang, Y. | 2011
PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)
Ofierska-Sujkowska, G. / Jagodzinska-Kalinowska, K. / Matusewicz, W. | 2011
PHP84 AHRQ VERSUS NICE: DO THE CONCLUSIONS IN CER REPORTS CORRESPOND CLOSELY TO THE COMPARATIVE EFFECTIVENESS ASSESSMENTS MADE IN HTA REPORTS?
Alnwick, K. | 2011
CE1 COST-EFFECTIVENESS SENSITIVITY ANALYSIS METHODS: A COMPARISON OF ONE-WAY SENSITIVITY, ANALYSIS OF COVARIANCE, AND EXPECTED VALUE OF PARTIAL PERFECT INFORMATION
Campbell, J. / McQueen, R. B. / Libby, A. / Briggs, A. | 2011
PCV28 CARDIOVASCULAR RISK FACTORS AMONG CHINESE AND WHITE ADULTS IN THE UNITED STATES
McDonald, M. / Zhou, J. / Rubinstein, E. / Mardekian, J. | 2011
PCV66 ADHERENCE RATES AMONG HEALTH PLAN MEMBERS STARTING GENERIC VERSUS BRAND STATIN THERAPY
Chen, Q. / Kachur, S. G. / Fatodu, H. / Garber, H. | 2011
PCV85 TREATMENT FOR DEPRESSION IN WOMEN WITH HYPERTENSION
Atkins, E. / Sambamoorthi, U. | 2011
PHP89 THE IMPLEMENTATION OF PUBLIC HEALTH GUIDANCE: PREFERENCE FOR CLINICAL OVER BEHAVIOURAL INTERVENTIONS
Hamerslag, L. / Kusel, J. / Haynes, S. / Brooks-Rooney, C. / Costello, S. | 2011
PSU3 LONG-TERM CLINICAL EFFECTIVENESS AND STABILITY OF LASIK AND SURFACE ABLATION IN KOREA: A SYSTEMATIC REVIEW APPROACH
Lee, N. R. / Choi, J. / Jang, E. J. / Jung, S. Y. / Lee, E. J. / Joo, C. K. | 2011
PMD24 GLYCOSYLATED HEMOGLOBIN OR FASTING GLUCOSE TESTING FOR SCREENING DIABETES IN COLOMBIA: A COST-EFFECTIVENESS ANALYSIS
Vecino-Ortiz, A. I. / Garrison, L. / Alfonso-Cristancho, R. | 2011
PCV65 NEW STATIN USERS' PERSISTENCE AND ADHERENCE: BOTH ARE CRITICAL CONCEPTS IN THE COMPREHENSIVE CHARACTERIZATION OF MEDICATION EXPOSURE
Slejko, J. F. / Valuck, R. J. / Ho, P. M. / Anderson, H. D. / Nair, K. V. / Campbell, J. D. | 2011
PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION
Kowalski, J. / Yeh, W. S. / O'Leary, B. / Ackerman, S. / Sharma, S. / Adena, M. | 2011
PCN5 USING HEALTH CLAIMS DATA TO STUDY PATTERNS OF CERVICAL CANCER SCREENING AND DIAGNOSIS IN A STATE MEDICAID FEE-FOR-SERVICE POPULATION (FUNDING: AHRQ – P20-HS15930)
Nadpara, P. / Madhavan, S. / Khanna, R. / Atkins, E. / Smith, M. J. / Miller, L. A. | 2011
PDB29 DIRECT MEDICAL COST OF HYPOGLYCEMIA AMONG PATIENTS WITH TYPE-2 DIABETES IN THE UNITED STATES
Curkendall, S. / Zhang, B. / Oh, K. / Williams, S. / Pollack, M. / Graham, J. P. | 2011
PHP92 RESULTS OF A PHARMACY MANAGEMENT PROGRAM FOR IMPROVING MEDICATION ADHERENCE
Regine, M. L. / Bunz, T. J. | 2011
PIN12 ECONOMIC ANALYSIS OF CEFTIOFUR HYDROCHLORIDE FOR TREATMENT OF BOVINE CLINICAL MASTITIS CAUSED BY GRAM-NEGATIVE PATHOGENS IN DAIRY COWS IN THE UNITED STATES
Poulsen Nautrup, B. / Van Vlaenderen, I. / Postorino-Reeves, N. / Gasper, S. | 2011
PIH16 COST-EFFECTIVENESS OF DESVENLAFAXINE FOR THE TREATMENT OF VASOMOTOR SYMPTOMS IN BREAST CANCER PATIENTS IN MEXICO
Ram&#x00ED / rez-Ram&#x00ED / rez, M. A. / Peniche-Otero, G. / Mould-Quevedo, J. F. / Nu&#x00F1 / o-Langre, C. / Muci&#x00F1 / o-Ortega, E. / Galindo-Suarez, R. M. | 2011
PIH29 THE ROLE OF GENERATIONAL INFLUENCE TOWARDS COMPLEMENTARY AND ALTERNATIVE MEDICINE
Mhatre, S. K. / Artani, S. M. / Sansgiry, S. S. | 2011
PCN17 MULTI-COHORT MODEL OF PREVALENCE ESTIMATION OF ADVANCED MALIGNANT MELANOMA IN THE UNITED STATES: RESULTS COMPARED TO SEER DATA
Lin, A. Y. / Wang, F. / Kolker, J. A. | 2011
PCN26 BUDGET IMPACT MODEL OF DENOSUMAB FOR SKELETAL RELATED EVENT (SRE) PREVENTION IN PATIENTS WITH BREAST AND PROSTATE CANCER
Northridge, K. / Richhariya, A. / Halperin, M. / Chung, K. / Danese, M. D. | 2011
PCN32 COMPARISON OF EPOETIN ALFA AND DARBEPOETIN ALFA DOSING PATTERNS AND COSTS IN CHRONIC KIDNEY DISEASE AND CHEMOTHERAPY-INDUCED ANEMIA OUTPATIENTS
Lafeuille, M. H. / Bailey, R. A. / Senbetta, M. / McKenzie, R. S. / Lefebvre, P. | 2011
PCN33 COST SAVINGS ASSOCIATED WITH TRANSFUSION INDEPENDENCE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH A 5Q- DELETION
Bozkaya, D. / Mahmoud, D. / Mitsi, G. / Khan, Z. M. | 2011
PSY18 A DECISION ANALYSIS MODEL EXPLORING THE RESULTS OF A PHASE II TRIAL OF ELTROMBOPAG FOR PATIENTS WITH CHRONIC HEPATITIS C, CIRRHOSIS AND THROMBOCYTOPENIA
Schelfhout, J. / Kauf, T. | 2011
PRM45 PILOT TESTING TRANSLATIONS OF PRO MEASURES WITH SENSITIVE POPULATIONS
Verjee-Lorenz, A. / Clayson, D. / Two, R. | 2011
PDB28 COST SAVINGS IN TYPE-2 DIABETES (T2D) WITH INSULIN GLARGINE COMPARED WITH INSULIN DETEMIR IN THE UNITED KINGDOM
Tilling, C. / Evans, L. M. / Keech, M. | 2011
PCN71 USING MEASURES OF SOCIETAL VALUE AND ECONOMIC MODELING TO ESTIMATE PRICES FOR CANCER DRUGS IN SOUTH AFRICA
Dranitsaris, G. / Truter, I. / Lubbe, M. / Fourie, S. | 2011
PCN92 PSYCHOMETRIC COMPARISION OF THE EQ-5D-3L TO THE EQ-5D-5L IN CANCER PATIENTS IN KOREA
Kim, S. H. / Jo, M. W. | 2011
PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT
Lachaine, J. / Beauchemin, C. / Goyette, A. / Martel, M. J. | 2011
PMH4 RISK OF FALLS AND FRACTURES IN OLDER ADULTS USING ATYPICAL ANTIPSYCHOTICS-A MULTIPLE PROPENSTY SCORE ADJUSTED RETROSPECTIVE COHORT STUDY
Chatterjee, S. / Chen, H. / Johnson, M. L. / Aparasu, R. R. | 2011
PMH49 CAN THE ILLNESS PERCEPTION QUESTIONNAIRE BE USED TO ASSESS MENTAL HEALTH PRACTITIONERS' PERSPECTIVES ON PATIENTS WITH SCHIZOPHRENIA?
Fleming, M. / Martin, C. R. | 2011
PMH53 ASSESSING THE IMPACT OF MAJOR DEPRESSIVE DISORDER (MDD) ON FAMILY FUNCTIONING: DEVELOPMENT OF THE DEPRESSION AND FAMILY FUNCTIONING SCALE
Lan&#x00E7 / on, C. / DiBenedetti, D. B. / Lewis, S. / Davis, K. / Danchenko, N. / Fran&#x00E7 / ois, C. | 2011
PMH51 BASELINE RESULTS FROM BEAT THE BLUES
Pizzi, L. T. / Jutkowitz, E. / Gitlin, L. / Suh, D. C. / Dennis, M. | 2011
PMH1 IS STIMULANT OR ATOMOXETINE UTILIZATION ASSOCIATED WITH NEUROLOGICAL ADVERSE EVENTS IN CHILDREN WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER (ADHD)? A RETROSPECTIVE ANALYSIS OF PROPENSITY SCORE MATCHED DATA
Bhattacharjee, S. / Chen, H. / Bhatara, V. / Aparasu, R. R. | 2011
PCN127 METHODS FOR INDIRECT COMPARISON OF EFFECTIVENESS IN COST-EFFECTIVENESS ANALYSES OF ONCOLOGY AGENTS: THE PROPORTIONAL HAZARDS ASSUMPTION MATTERS
Ducournau, P. / Zhao, Z. / Barber, B. / Gao, S. / Graham, C. N. | 2011
PGI3 THE LIKELIHOOD OF HAVING FUNCTIONAL DYSPEPSIA BASED ON OTHER COMORBID CONDITIONS
Brook, R. A. / Talley, N. J. / Choung, R. S. / Smeeding, J. / Kleinman, N. L. | 2011
PMH58 NEW DISEASE MANAGEMENT PROGRAM FOR OPIOID DEPENDENT PATIENTS DECREASES DRUG USE AND INCREASES 12 STEP MEETING ATTENDANCE: ONE YEAR RESULTS OF A RANDOMIZED CLINICAL TRIAL
Tkacz, J. / Ruetsch, C. | 2011
PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNIT
Lachaine, J. / Beauchemin, C. | 2011
PCV46 LONG-TERM COSTS AND HEALTH OUTCOMES OF TREATING ACUTE CORONARY SYNDROME PATIENTS WITH TICAGRELOR BASED ON THE EU LABEL - COST-EFFECTIVENESS ANALYSIS BASED ON THE PLATO STUDY
Henriksson, M. / Nikolic, E. / Janzon, M. / Hauch, O. / Levin, L. x. / Wallentin, L. | 2011
PCV69 IMPACT OF COMMUNITY PHARMACIST-LED COUNSELING ON IMPROVING MEDICATION ADHRERENCE
Jiang, J. Z. / Khandelwal, N. / Rudkin, K. / Duncan, I. | 2011
PSS18 DISEASE SEVERITY EVALUATION AMONG DERMATOLOGICAL OUT-PATIENTS: A COMPARISON BETWEEN THE ASSESSMENTS OF PATIENTS AND PHYSICIANS
Tabolli, S. / Sampogna, F. / Pagliarello, C. / Paradisi, A. / Spagnoli, A. / Abeni, D. | 2011
PSS27 EFFECT OF TREATMENT SWITCH ON THE COST-EFFECTIVENESS OF BIOLOGICS IN PSORIASIS IN PERU AND COLOMBIA
Alandete, J. C. | 2011
PSY1 SEVERE RENAL, HEPATIC AND GASTROINTESTINAL EVENTS ASSOCIATED WITH DEFERASIROX IN PATIENTS WITH TRANSFUSION-DEPENDENT ANEMIA
Huang, W. F. / Hsiao, F. Y. / Chou, H. C. / Tsai, Y. W. / Yen, H. C. / Ke, W. M. | 2011
PSY9 HEALTH CONSEQUENCES AND COSTS OF TACHOSIL® AS HAEMOSTATIC TREATMENT IN LIVER SURGERY VERSUS TISSUCOL®: A RETROSPECTIVE OBSERVATIONAL COHORT STUDY
Ortega, A. / Pardo, F. | 2011
PHP109 AN OUTCOMES PROFILE REGISTRY FOR ESTABLISHING A BASELINE MATRIX IN COMPARATIVE EFFECTIVENESS STUDIES IN PREDICTIVE PHARMACOLOGY
Wheeler, C. | 2011
PSS29 DEVELOPMENT OF THE MODIFIED OCULAR COMFORT INDEX (MOCI)
Johnson, M. E. / Ruiz, W. M. / Li, J. Z. | 2011
PRM27 SF-12 AND EQ-5D UTILITY SCORING STRATEGY: LESSONS FROM APPLYING 40 SCORINGS TO 3 LARGE DATA SETS
Miller, T. R. / Bhattacharya, S. | 2011
PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)
Tarride, J. E. / Harrington, K. / Balfour, R. / Simpson, P. / Foord, L. / Anderson, L. / Lakey, W. K. | 2011
PSY68 DEFINITIONS OF ANTI-TNF DISCONTINUATION MAY IMPACT UNDERSTANDING OF REAL-WORLD UTILIZATION PATTERNS
Schmeichel-Mueller, C. / Buysman, E. / Bolge, S. / Ingham, M. / McKenzie, R. S. | 2011
PUK3 DRUG-INDUCED ACUTE RENAL FAILURE USING THE FDA ADVERSE EVENT REPORTING SYSTEM DATABASE
Alhammad, A. M. / Al Hawaj, M. A. / Alsalman, A. J. / Alhashem, Y. N. / Harpe, S. E. / Smith, W. R. / Brophy, D. F. | 2011
PMS13 OSTEOPOROSIS-RELATED FRACTURE COSTS AMONG FEMALE COMMERCIALLY INSURED AND MEDICARE PATIENTS
Bonafede, M. / Shi, N. / Viswanathan, H. N. / Yurgin, N. | 2011
PRS30 COMPARISON OF CLINICAL AND PATIENT-REPORTED OUTCOME MEASURES IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE
Yang, Y. / Pickard, A. S. / Lee, T. | 2011
PSU8 PATTERNS OF ACUTE CLOPIDOGREL USE AND INPATIENT COSTS IN ACUTE CORONARY SYNDROME PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
Johnston, S. S. / Bell, K. / Gdovin Bergeson, J. / McMorrow, D. / Graham, J. | 2011
PDB21 A COST COMPARISON OF A BASAL BOLUS REGIMEN (INSULIN GLARGINE AND INSULIN GLULISINE) WITH A CONVENTIONAL PRE-MIXED INSULIN REGIMEN IN TYPE-2 DIABETES PATIENTS – THE GINGER STUDY
Tilling, C. / Vora, J. / Keech, M. | 2011
PRM28 CREATION OF A NEW PSORIASIS QUALITY OF LIFE MEASURE FROM FIVE PREEXISTENT INSTRUMENTS USING RASCH ANALYSIS: THE CALIPSO QUESTIONNAIRE
Sampogna, F. / Styles, I. / Tabolli, S. / Abeni, D. | 2011
PCN11 COMPARATIVE EFFECTIVENESS RESEARCH: ERECTILE DYSFUNCTION LONGITUDINAL COSTS ACROSS TREATMENTS FOR PROSTATE CANCER
Wilson, L. S. / Basu, R. / Paoli, C. / Lian, V. / Wong, A. / Kuo, J. / Sadetsky, N. / Cooperberg, M. / Carroll, P. | 2011
PRM44 OPTIMUM METHODS FOR PRO TRANSLATION AND LINGUISTIC VALIDATION METHODOLOGY: ONE BACK TRANSLATION OR TWO?
Furtado, T. / Anderson, H. / Griffin, A. / Wild, D. | 2011
PSY71 HEALTH AND FUNCTIONAL STATUS FOR INDIVIDUALS WITH THROMBOCYTOPENIA IN THE UNITED STATES: EVIDENCE FROM NHANES
Kauf, T. / Schelfhout, J. / Nelson, D. R. / Wang, P. F. | 2011
PMS71 COMPARISON OF PROPENSITY SCORE MATCHING AND INSTRUMENTAL VARIABLE METHODS WHEN ESTIMATING HEALTH CARE COSTS OF RHEUMATOID ARTHRITIS PATIENTS
Baser, O. / Xie, L. / Wang, L. / Du, J. | 2011
PRS8 DISEASE PROGRESSION IN CYSTIC FIBROSIS — SYNTHESIS OF SURVIVAL EVIDENCE
Becker, C. C. / Vieira, M. C. / Harrow, B. / Liou, T. G. / Jansen, J. P. | 2011
PRS16 COST-EFFECTIVENESS OF VARENICLINE VERSUS EXISTING SMOKING CESSATION STRATEGIES IN CENTRAL AMERICA AND THE CARIBBEAN USING THE BENESCO MODEL
Lutz, M. / Lovato, P. / Cuesta, G. | 2011
PDB14 USING HEALTH OUTCOMES MODELING TO ASSESS THE BENEFIT-RISK PROFILE OF EXENATIDE ONCE-WEEKLY VERSUS INSULIN GLARGINE FOR PATIENTS WITH TYPE-2 DIABETES
Garrison, L. / Best, J. H. / Robertson, J. C. / Wenten, M. / Bruhn, D. | 2011
PIH27 DIFFERENCES IN PATIENT SATISFACTION WITH PRIMARY CARE AND SPECIALTY CARE
Wu, J. / Adolph, M. D. / Feldman, S. R. / Balkrishnan, R. | 2011
PIH22 PRIMARY MEDICATION NONADHERENCE: A RETROSPECTIVE ANALYSIS OF ELECTRONIC PRESCRIPTIONS IN AN INTEGRATED HEALTHCARE SETTING
Shin, J. / Cheetham, C. T. / Sanchez, R. J. / Deminski, M. C. / Udall, M. / Vansomphone, S. S. / McCombs, J. | 2011
PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATES
Cost, P. / Snyder, T. / Zaidi, Q. | 2011
PIN33 COST-UTILITY ANALYSIS OF RALTEGRAVIR IN HIV-INFECTED TREATMENT NAïVE PATIENTS IN SWEDEN
Chaudhary, M. / Elbasha, E. H. / Kumar, R. N. / Lundberg, J. | 2011
PCV13 BURDEN OF COMORBIDITIES AMONG PATIENTS WITH ATRIAL FIBRILLATION
LaMori, J. C. / Gross, H. J. / Patel, A. A. / Crain, M. / DiBonaventura, M. D. / Mody, S. H. / Schein, J. | 2011
PIH46 SPECIAL PRECAUTIONS TO CONSIDER WHEN PERFORMING COGNITIVE DEBRIEFING OF SENSITIVE TOPICS
Gawlicki, M. / Handa, M. / McKown, S. | 2011
PIN15 ECONOMIC BURDEN OF SURGICAL SITE INFECTIONS IN HIP AND KNEE ARTHROPLASTY - A COST-OF-ILLNESS-STUDY FOR GERMANY
Hanstein, T. J. / Gaiser, G. | 2011
PCV27 IS ANEMIA ASSOCIATED WITH HEART FAILURE? NHANES DATABASE (2005-2006) ANALYSIS
Alsalman, A. J. / Alhammad, A. M. / Alhashem, Y. N. / Al Hawaj, M. A. / Van Tassell, B. W. / Harpe, S. E. | 2011
PCV23 COMPARING THE EFFECTIVENESS OF ROSUVASTATIN AND ATORVASTATIN IN PREVENTING CARDIOVASCULAR OUTCOMES: ESTIMATES USING THE ARCHIMEDES MODEL
Schuetz, C. A. / van Herick, A. / Alperin, P. / Peskin, B. / Hsia, J. / Gandhi, S. K. | 2011
PCV21 EFFECTS OF AZILSARTAN MEDOXOMIL VERSUS VALSARTAN AND OLMESARTAN MEDOXOMIL ON THE ACHIEVEMENT OF SYSTOLIC BLOOD PRESSURE GOALS AMONG HYPERTENSIVE PATIENTS WITH DIABETES
Sussman, M. / Leahy, M. / Friedman, M. / Menzin, J. / Nichols, C. / Neumann, P. / Sullivan, S. D. | 2011
PIN40 DO PATIENTS AND PHYSICIANS HAVE SIMILAR PREFERENCES FOR HEALTH CARE DECISIONS INVOLVING UNCERTAIN OUTCOMES FOR CHRONIC HEPATITIS B IN GERMANY AND TURKEY?
Lescrauwaet, B. / Mohamed, A. F. / Johnson, F. R. / Hauber, A. B. | 2011
PCV38 POTENTIAL ECONOMIC IMPACT OF DYSPNEA ASSOCIATED WITH TICAGRELOR USE
Bonafede, M. / Jing, Y. / Gdovin Bergeson, J. / Liffmann, D. K. / Makenbaeva, D. / Graham, J. P. / Deitelzweig, S. | 2011
PCN62 BAYESIAN MODELLING ASSESSING THE EFFECTIVENESS OF A VACCINATION STRATEGY TO PREVENT HPV-RELATED DISEASES: THE BEST STUDY
Mennini, F. S. / Baio, G. / Capone, A. / Marcellusi, A. / Favato, G. / Costa, S. / Garganese, G. / Picardo, M. / Drummond, M. / Jonsson, B. | 2011
PSY33 EXPLORING THE FACTOR STRUCTURE OF THE PROMIS FATIGUE ITEM BANK IN PATIENTS WITH FIBROMYALGIA
Schilling, S. / Blum, S. I. / Tourkodimitris, S. / Williams, D. A. | 2011
PCN6 BREAST, PROSTATE AND COLORECTAL CANCER SCREENING BEHAVIOR AND INCIDENCE OF LATE STAGE CANCER DIAGNOSIS IN ELDERLY WEST VIRGINIANS
Nadpara, P. / Madhavan, S. / Tworek, C. | 2011
PSY78 ESTIMATING THE BMI-MORTALITY RELATION USING FRACTIONAL POLYNOMIALS
Wong, E. / Wang, B. C. / Garrison, L. / Alfonso-Cristancho, R. / Flum, D. / Arterburn, D. / Sullivan, S. D. | 2011

Wie erhalte ich diesen Titel?

Feedback